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2. Abstract  
Poly(L-lactide-co-ε-caprolactone) (poly(LLA-co-CL)) meets many of the requirements 
of a scaffolding material for bone tissue engineering, such as adequate 
biocompatibility, degradability, and tunable properties. However, poly(LLA-co-CL) 
scaffolding tends to be hydrophobic and does not favor cellular attachment and 
differentiation. The overall purpose of this research project was to improve the 
physical and chemical properties of poly(LLA-co-CL) scaffolds to enhance biological 
responses. The modifying effects were evaluated and characterized in vitro and in vivo.  
The aim of Paper I was to compare the influence on bone regeneration of low 
(1 × 106 cells/scaffold) and high (2 × 106 cells/scaffold) seeding densities of bone 
marrow stromal stem cells (BMSCs) onto poly(LLA-co-CL) scaffolds. The influence 
of osteogenic supplements was also assessed. Scaffolds seeded at high cell density 
exhibited higher mRNA expressions of osteogenic markers than those with low 
seeding density. Osteogenic supplements significantly increased cell proliferation; 
more bone was formed in response to high seeding density with osteogenic medium. 
The results show that cell seeding density and osteogenic supplements may have a 
synergistic effect on the induction of new bone. 
After optimizing the culture conditions for BMSCs, the hydrophilicity of the 
surfaces of poly(LLA-co-CL) scaffolding was increased, either by blending with 
Tween 80 (Paper II), or coating with nanodiamond particles (nDPs) (Paper III). 
 Compared with pristine scaffolds, the modified poly(LLA-co-CL) scaffolds 
exhibited reduced albumin adsorption and significantly increased the seeding 
efficiency of BMSCs.  
In Paper II, poly(LLA-co-CL)/3% Tween 80 scaffolds implanted 
subcutaneously in rats exhibited significantly increased mRNA expression of Runx2 
and de novo bone formation. In Paper III, BMSCs-seeded into poly(LLA-co-
CL)/nDPs scaffolds were implanted into rat calvarial defects and live imaging at 12 
weeks disclosed significantly increased osteogenic metabolic activity. Micro-
computed tomography, confirmed by histological data, revealed a substantial increase 
in bone volume.  
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These results show that increasing the density of cell seeding onto poly(LLA-
co-Cl) scaffolds promotes BMSCs differentiation and bone formation. Modifying the 
surface of poly(LLA-co-CL) scaffolds to improve hydrophilicity promotes 
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Allogenic: “From individuals of the same species” 
Allograft: “Graft harvested from an individual other than the one receiving the graft” 
Autograft: “Graft obtained from the same individual receiving the graft” 
Autologous: “Originating from the recipient rather than from a donor” 
Biodegradation: “Capable of being decomposed by bacteria or other biological 
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Extracellular matrix: “Collection molecules secreted by cells that provide structural 
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Ex vivo: “Experimentation or measurements done in or on tissue from an organism in 
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In vivo: “Taking place in a living organism” 
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Osteoclast: “A large multinucleate bone cell which absorbs bone tissue during growth 
and healing” 
Osteoconductive: “Supports bone growth and encourages the ingrowth of surrounding 
bone” 
Osteocyte: “A bone cell that is formed when an osteoblast becomes embedded in the 
material it has secreted” 
Osteogenesis: “When vital osteoblasts originating from the bone graft material 
contribute to new bone growth” 
Osteoid: “Unmineralized and/or collagenous organic component of bone” 
Osteoinductive: Capable of promoting the differentiation of progenitor cells down an 
osteoblastic lineage 
Osteointegration: “Integrates into surrounding bone Strength Ability of a material to 
withstand an applied load without failure” 
Polymer: “A substance which has a molecular structure built up from a large number 
of similar units bonded together” 
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7.1 Bone Tissue Engineering  
“Look deep into nature, and then you will understand everything better”   
Albert Einstein   
Bone has a wide array of functions and responds to a variety of metabolic, physical, 
and endocrine stimuli. It is the basis of locomotion, stores biological elements required 
for hematopoiesis, provides the load-bearing skeleton, and protects the internal organs 
[1]. The adult human skeleton comprises more than 200 bones, consisting of two 
components: cortical (compact) and trabecular (cancellous) bone. Cortical bone, which 
comprises 80% of all bone tissue, is arranged in a compact solid pattern, with less than 
10% porosity and is generally present in long, short, and flat bones [1]. Trabecular 
bone, about 20% of all bone tissue, is structured in sponge-like pattern with porosity 
up to 50‒90%. It can be found in the bone marrow and is essentially present in the 
metaphysis of long bones, the iliac crest, and the vertebral bodies.  
Bone has the ability to regenerate without forming scar tissue. In addition, it is a 
highly dynamic tissue and constantly changes in response to mechanical and hormonal 
signals. The dynamic state of homeostasis is mediated by bone cells such as 
osteoblasts, osteoclasts, and osteocytes [1]. Osteoblasts are derived from mesenchymal 
stem cells (MSCs) and secrete osteoid. The osteocyte is a mature osteoblast, 
surrounded by osteoid. Osteoclasts, derived from hematopoietic cells of the marrow, 
secrete acids and proteolytic enzymes which dissolve mineral salts and digest the 
organic matrix of bone [1]. Bone can be considered as a truly composite material with 
bone matrix components, a mineral part (hydroxyapatite (HA)) which comprises 65‒
70% of the matrix and an organic part (collagen, glycoproteins, proteoglycans, and 
sialoproteins) which comprises the remaining 25‒30% of the total matrix [2]. However, 
the regenerative capacity of bone might be compromised when the defect size is 
beyond the normal potential for self-healing [3]. 
One of the challenges confronted by clinicians is the repair and restoration of 
bone defects resulting from congenital anomalies, resection of a neoplasm or trauma. 
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To date, the autologous bone graft has served as the gold standard because of 
histocompatiblity and other essential properties of a bone grafting material [4], 
necessary to achieve osteogenesis, osteoinduction, and osteoconduction [5]. However, 
in many cases, only a limited amount of bone is available and the procedure may be 
complicated by donor site morbidity and post-operative pain [6]. These limitations can 
be overcome by the use of allografts [6]. There are however, documented cases of 
infection transmission associated with allografts and the risks of bacterial 
contamination and immune rejection of the graft must be considered [6].  
Bone tissue engineering is a promising alternative approach to bone 
regeneration, circumventing such issues as insufficient donor tissue for transplanting 
and the potential risk of adverse tissue responses [7]. This dynamic process comprises a 
number of steps: recruitment of osteoprogenitor cells followed by their proliferation 
and differentiation, and matrix deposition and remodeling of the bone [8]. The classical 
concept of bone tissue engineering involves seeding of cells into a supporting 
structural framework called a scaffold: the cells are allowed to deposit a matrix before 
implantation of the seeded scaffold into the defect (Figure 1) [9]. Several studies of 
tissue engineering and regenerative medicine have shown that cells are important for 
stimulating bone regeneration [10-13]. This can be enhanced by exposure to certain 
signaling molecules or other growth factors which can be loaded into the scaffold [14]. 
In another approach, the scaffolding material may be implanted without cells and 
regeneration then relies on the recruitment of host native cells into the scaffolds and 
the subsequent deposition of an extracellular matrix (ECM) [15].  
Regardless of the approach being used, the scaffold is a fundamental component 
in bone tissue engineering.  
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Figure 1. Bone tissue engineering construct in which cells are seeded into 3D porous 
biomaterial scaffolds. Cells are isolated from the patient, cultured, and expanded in vitro on 
2D surfaces. The cells are then seeded into porous scaffolds, with or without growth factors, 
small molecules, and micro- and/or nanoparticles.  
The scaffolds act as a temporary extracellular matrix and provide high mass transfer and 
waste removal. Once functioning tissue has been successfully engineered, the construct is 
transplanted into the defect to restore function (Figure modified from [16]) 
 
7.1.1 Scaffolds for bone regeneration 
The scaffold functions as a template or ECM for cells or growth factors in regeneration 
of damaged tissues or organs [17]. Before implantation into the site of the defect, the 
construct is engineered by seeding cells into the 3D scaffold in vitro, and synthesizing 
tissues by dynamic cell culture [18]. After implantation, the engineered construct may 
influence the host by releasing osteogenic growth factors, or by housing cells that 
release growth factors [5]. This leads to accelerated cell homing and enhances 
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7.1.1.1 Benchmarks of scaffolds 
Because the scaffolds abut against such a sensitive and complex biological tissue as 
bone, there are stringent requirements for scaffold materials and scaffold design for 
application in bone tissue engineering. Biomimetic bone scaffolds are usually made of 
porous degradable materials which provide mechanical support during the 
regeneration process [9]. These scaffolds require specific physical and mechanical 
properties appropriate to the site of application.  
In order to simulate the characteristic features of native bone, composite scaffolds 
have been developed [17]. Scaffolding materials must be osteoinductive, i.e. capable of 
promoting differentiation of progenitor cells along an osteoblastic lineage; 
osteoconductive, i.e. allow the bone cells to adhere, proliferate, and form ECM on its 
surface, and capable of osseointegration i.e. integrate into the surrounding tissues [19].  
A successful biomimetic scaffold should meet the following requirements: 
i. Biocompatibility 
Biocompatibility refers to the ability to support normal cellular activity including 
molecular signaling systems, without any local or systemic toxic effects on the host 
tissue [20]. In vivo, the immune reaction to the implanted construct must be negligible, 
in order to prevent a severe inflammatory response which might impair healing or 
cause failure of the engineered constructs [20].   
ii. Degradability 
According to the concept of regenerative therapy, the implanted scaffolds should 
degrade and eventually be replaced by the newly formed tissues. Thus, scaffolds are 
not intended as permanent implants and should be biodegradable, with an appropriate 
degradation time in vivo, enhancing tissue ingrowth and subsequent formation of new 
bone [21, 22]. More specifically, the scaffold degradation rate should mirror the rate of 
bone formation. Another important requirement is that the by-products of the 
degradation process must be non-toxic and able to exit the body in some natural 
manner, without interfering with the regenerative process. Further, an inflammatory 
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response, combined with controlled infusion of cells such as macrophages, is required 
in order to allow degradation to occur in tandem with tissue formation [23].  
iii. Scaffold architecture and topography 
The physical features of the scaffold, defined by the micro-architecture (pore 
geometry, porosity, and interconnectivity) and the surface properties (surface 
topography), are known to have a profound influence on cell function [24]. In order to 
ensure cellular penetration, adequate diffusion of nutrients to cells within the construct 
and diffusion of waste products out of the scaffold, scaffolds should have 
interconnected pores and high porosity [17]. Under in vivo conditions, the success of the 
engineered construct depends on survival of growing cells and tissues within the 
scaffold through angiogenesis [25]. The interconnected pores facilitate rapid blood 
vessel formation in or around the implanted scaffolds to actively support nutrient, 
oxygen, and waste transport [17]. Pore sizes in the range of 100 – 500 μm have been 
found to be appropriate for bone tissue ingrowth [26].  
  Cells interact with scaffolds via chemical groups (ligands) on the material 
surface [17]. The density of ligands is influenced by the specific surface area, i.e. the 
available surface within a pore to which cells can adhere [17]. Thus, a large surface area 
favors cell attachment and growth [27].   
iv. Mechanical properties  
An essential function of bone tissue engineering scaffolds is to provide temporary 
mechanical integrity at the defect site until the bone tissue is regenerated and normal 
biomechanical function is restored [19]. For compact bone, Young's modulus is between 
15 and 20 GPa and for trabecular bone between 0.1 and 2 GPa. The compressive 
strength of compact bone ranges from 100 to 200 MPa; the range for trabecular bone is 
from 2 to 20 MPa [8]. The implanted scaffold must have sufficient mechanical integrity 
to function from the time of implantation to completion of the remodeling process [28].  
Scaffold mechanical strength affects the mechano-transduction of the adherent 
osteoblast or progenitor cells on the scaffold, which is critical to the bone regeneration 
and remodeling processes [29]. In mechano-transduction, the cells respond to stress by 
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producing more bone cells, i.e. a mechanical stimulus is converted into chemical 
activity [29]. Both high and low mechanical properties of a scaffold may affect the 
growth and integration of new tissue [30]. Moreover, increasing the porosity of the 
scaffolding material detracts from the mechanical properties and complicates the 
manufacture of reproducible scaffolding [8]. An appropriate construct for bone tissue 
engineering might be tailored by reinforcement of porous scaffolds with polymers, 
ceramics, composites, and metals. 
7.1.1.2 Candidate materials for scaffolds  
The market for materials for biomedical application is expanding rapidly. As the 
biomaterial matrix is a fundamental component of the temporary synthetic bone 
substitute, the choice of an appropriate biomaterial is the crucial step in the scaffold 
design process. It is essential to select biomaterials that fulfill scaffold criteria, with 
surface properties appropriate to the requirements of the clinical site. Scaffold 
materials can be organic or inorganic, natural or synthetic, degradable or non-
degradable, depending on the intended use [31]. 
Porous metallic scaffolds, predominantly made of magnesium (Mg), titanium 
(Ti), and tantalum (Ta), have been studied as materials in bone replacement [32-34]. 
Metals have high compressive strengths and excellent fatigue resistance, but cannot be 
integrated and are not biodegradable. Moreover, there are concerns about the release of 
metal ions into the surrounding tissues [35].  
Ceramics have high biocompatibility and are similar to the mineral phase of 
bone [19]. The calcium phosphate (CaP), group consisting of HA and tricalcium 
phosphate, is the most commonly used in bone tissue engineering [19]. However, the 
potential clinical application is limited because ceramics are brittle, with a tendency to 
fracture and have poor biodegradability [36].  
Polymers are the most commonly studied biomaterials for tissue engineering, 
followed by ceramics [37]. The polymeric biomaterials vary widely, depending on the 
source, composition, and structure. In addition, the polymers can often be reinforced 
with other materials and used as composites [36]. A number of natural polymers has 
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been developed and identified as biomaterials, differing in terms of chemical structure 
and composition such as protein, polysaccharide, and polyhydroxyalkanoate content. 
Collagen, chitosan, and hyaluronic acid are attractive scaffold materials and were the 
first biodegradable biomaterials tested for clinical application [38]. Owing to their 
bioactive properties, natural polymers have better interactions with the cells, thus 
enhancing the cellular events in biological systems [38]. They are also used as coating 
or blending materials to improve cell-material interactions on synthetic polymeric 
devices [21]. However, this inherent bioactivity has some disadvantages: complications 
and difficulties associated with their purification, strong immunogenic responses, and 
the potential for transmission of disease. In addition, the mechanical properties and 
batch to batch variations of natural polymers limit their application [19].  
Synthetic biomaterials on the other hand, have been widely studied and offer a 
versatile alternative. Their properties (e.g. degradation time, porosity, and mechanical 
features) can be tailored for specific applications. Some of synthetic polymers have 
physico-chemical and mechanical properties comparable with natural tissues and 
represent the largest group of biodegradable polymers [39]. Aliphatic polyesters are 
notable for their great diversity and synthetic adaptability. Polyesters can be developed 
from different monomers via e.g. ring opening and condensation polymerization routes 
depending on the monomeric units [40]. The aliphatic polyesters include poly(glycolide) 
(PGA), poly(lactide) (PLA), and poly(caprolactone) (PCL). These are the most widely 
used biomaterials. They are synthesized using different polymerization methods such 
as ring-opening polymerization of the respective cyclic monomers; catalysts and 
initiators must be used. However, aliphatic polyesters generally lack mechanical 
strength and load bearing applications may be contraindicated [39]. Moreover, the 
degradation rates are either too fast or too slow [41].  
Various monomers have been co-polymerized [39]. Poly(lactide-co-glycolide) 
(PLGA) copolymers have been widely investigated, because they exhibit important 
properties such as adjustability of degradation rates and excellent processability [42]. 
PLGA have been approved by the US Food and Drug Administration (FDA) for 
clinical use, such as bioresorbable sutures [43]. However, despite biocompatibility and 
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controllable degradation, clinical application of pure PLGA for bone regeneration is 
limited because of poor osteoconductivity and mechanical properties which are 
inadequate to withstand load-bearing applications [42]. In order to render PLGA more 
biomimetic and able to enhance regeneration of bone, PLGA is therefore often 
functionalized or combined with other materials, such as ceramics [39, 42].  
Degradable PLA, PCL, and their co-polymers have received FDA approval for 
application in drug delivery and a number of medical devices [44]. They are also very 
promising for scaffold production [22]. Copolymers can be produced with different 
ratios of monomers: the chemical and physical properties of the resultant copolymer 
depend on the monomer ratio within the copolymer. It has been shown that poly(L-
lactide-co-ε-caprolactone) (poly(LLA-co-CL)) with 25 mol% ε-CL provides suitable 
properties as scaffolding for bone tissue engineering [22]. The degradation mechanism 
of poly(LLA-co-CL) starts with random hydrolysis ester cleavage and ends with 
weight loss through the diffusion of degraded compounds, which are usually oligomers 
[22]. It can be degraded by several mechanisms (by microorganisms, by bulk 
hydrolysis, and by enzymatic surface erosion), making it suitable for biomedical 
applications [22, 45]. The major advantages of poly(LLA-co-CL) as scaffolding material 
are better osteoinductive potential, and good mechanical properties [22, 46-48]. However, 
poly(LLA-co-CL) is hydrophobic, which might not favor stem cell attachment and 
differentiation [49]. Moreover, the inadequate mechanical properties (depending on 
scaffold design) may limit load-bearing applications [27].  
7.1.1.3 Degradation of polymer scaffolds 
Polymer degradation is defined as “the chemical changes in a polymeric material 
resulting in a cleavage of main-chain ester bonds producing shorter oligomers, 
monomers, and/or other low molecular weight degradation products” [50]. The 
degradation rate of polymer scaffolds depends on several factors including surface 
hydrophilicity, chemical composition, molar mass, degree of crystallinity, and the 
geometry of the scaffolds [51]. In addition, the degradation mechanism influences 
polymer structure and the environment it is subjected to e.g. oxygen, the presence of 
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moisture, microorganisms, pH, enzymes, and temperature [52]. The effects of pore size 
and porosity have been investigated, but the reported results are inconsistent [53, 54].  
Among synthetic polymers, aliphatic polyesters are degraded by cleaving the 
ester bond, either by passive hydrolysis, or actively, by enzymatic reaction which can 
proceed via surface or bulk-degradation pathways [50, 55]. The degradation of polyester 
scaffolds occurs in three stages. In the first stage the measured mechanical properties 
and structural integrity remain constant, while the relative number average molecular 
weights start to decrease. The second stage begins when the Young’s modulus of the 
scaffold decreases, but weight loss and structural changes are not yet significant. The 
third stage begins with the first significant weight loss and lasts until complete 
dissolution of the material [41]. It has been shown that the time required for the 
degradation of the copolymer is related to the ratio of monomers used in its production 
[41]. For instance, the higher the content of PGA in PLGA, the shorter the degradation 
time [41].  
The degradation rates of polymeric scaffolds can be tailored by additives, which 
promote degradation for example, poly(d,l-lactide) (PDLA) scaffolds can be blended 
with PLGA, poly(lactide-b-ethylene glycol-b-lactide), and a lactide [56]. A weight loss 
of 65% was recorded in the blended material, which is much greater than pure PDLA. 
The degradation rate of a polymer may also be influenced by adjusting the 
hydrophobicity. In a previous report, grafting high amounts of nano-HA onto PLA 
resulted in a degradation rate longer than that of pure PLA [57]. This has been attributed 
to reduced hydrophobicity as well as an increase in the surface area. In another study, 
PCL scaffolds modified with β-Tri-calcium phosphate exhibited an accelerated the 
degradation rate compared with PCL scaffolds, due to increased water diffusion: 
PCL/TCP scaffolds were more hydrophilic than PCL scaffolds [58]. Instead of adding a 
promoter to enhance the degradation rate of polyesters, it has been shown that adding 
nano-HA can also slow the degradation rate [59]. It is hypothesized that the presence of 
nHA neutralizes the acidic degradation products, which might reduce auto-hydrolysis 
and therefore the degradation.  
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7.1.1.4 Polymer scaffold fabrication techniques  
In addition to biomaterial chemistry, the maximum functional properties of scaffolds 
and their interactions with the seeded cells depend on the processing technique [60]. In 
the body, cells and tissues are organized into 3D architecture. Thus, to engineer 
functional tissues successfully, the scaffolds have to be designed to facilitate cell 
distribution and guide regeneration of tissue three dimensionally. Scaffold design and 
fabrication techniques influence morphology, pore size, and interconnectivity. These 
scaffolding characteristics strongly affect cellular events and must therefore be taken 
into account in bone regeneration techniques [60]. The rapid growth in the field of tissue 
engineering has resulted in a plethora of technologies for tailoring various porous 
synthetic scaffolds.  
Conventional techniques to produce scaffolds have focused mainly on the 
introduction of open and interconnected pores within biodegradable scaffolds, in order 
to increase the viability of the seeded cells. In particular, the salt leaching technique 
has been widely used because it is cost-effective, simple, and easy to scale up [61]. 
Numerous scaffolds prepared from this technique might result in successful clinical 
outcomes [62]. However, the technique can produce only thin scaffolds or membranes 
up to 3 mm thick and it is very difficult to reproduce scaffolds with accurate pore 
interconnectivity [63].  
As an alternative, electrospinning allows nanoscaled fibrous design of scaffolds 
that mimic functional collagen structures [64]. These nanofibers are characterized by a 
complex interconnective fibrous structure, which may make it possible to fabricate 
highly structured scaffolds for inducing cellular events [65]. During the last decade, 
rapid prototyping (RP) techniques have been introduced including selective shape 
deposition manufacturing, laser sintering, fused deposition modeling, 3D bio-plotting, 
and stereolithography. The scaffolds fabricated by these techniques are precise and 
reproducible, controlling the internal pore size, pore interconnectivity, porosity, and 
mechanical performance [65]. In addition, they are considered to be effective methods 
for fabricating custom-made scaffolds [65, 66].   
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7.1.2. Cell-based strategies in bone tissue engineering 
The potential of the cell-based strategy has been demonstrated in several in vitro and 
in vivo preclinical studies [10-13]. However, to date there has been no extensive 
translation of these results to clinical bone regenerative applications [67]. Despite 
promising data, several factors have contributed to the fact that bone tissue 
engineering has not yet become an established clinical procedure [5].  
Multipotent stromal cells or mesenchymal stem cells (MSCs) are the most 
extensively investigated and applied [68]. These cells are non-hematopoietic and of 
mesodermal derivation, capable of self-renewal and multilineage differentiation e.g. 
into osteoblasts, adipocytes, and chondrocytes [67]. MSCs are found throughout the 
body and numerous extraction protocols have been established for different tissues e.g. 
umbilical cord [69], adipose tissue [70], skeletal muscle [71], deciduous teeth [72], and other 
tissues. For more than 40 years, bone marrow-derived stem cells (BMSCs) have been 
the most frequent sources for cell therapy [73]. These cells can be isolated from bone 
marrow and from bone chips (cortical or trabecular bone).  
A series of reports on preclinical studies has confirmed that BMSCs can induce 
formation of new bone [10, 11] due to their proliferation and differentiation capacities [10-
13]. There are also a limited number of clinical trials demonstrating the stimulatory 
osteogenic effect of BMSCs [12, 13]. However, it has been shown that the proliferative 
capacity and differentiation potential of BMSCs are inversely correlated with donor 
age [74]. BMSCs have been found to be positive for STRO-1, SH3, CD29, CD44, 
CD71, CD90, CD105, CD106, CD120a and CD124 and negative for negative CD14, 
CD34, and CD45 [75].  
Autologous BMSCs are the most commonly used in regenerative medicine [76]. 
However, a major disadvantage is the difficulty in harvesting a sufficient number of 
cells, particular in elderly patients [74]. Tissue regeneration requires a minimum number 
of cells for each application: thus ex vivo expansion and multiplication of the harvested 
cells may be necessary. This expansion procedure requires a clean cell processing 
environment to avoid any kind of contamination. In addition, it is a time consuming 
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procedure and there is a risk of viral infection from serum supplementation in the 
culture medium [77].  
7.1.2.1 Cell expansion   
After isolation of BMSCs, ex vivo expansion is a vital step. The goal is to achieve a 
sufficient number of undifferentiated stem cells capable of efficiently differentiating 
into osteoblast-like cells. For reproducible expansion of BMSCs, essential culture 
parameters need to be considered, such as the type of culture medium, cell passaging 
density, and doubling numbers. It is often, necessary to grow millions of BMSCs in 
vitro, thus, significant cell proliferation is required. It has been reported that rapid 
proliferation of BMSCs could result in an expansion of a thousand-fold in 14 to 21 
days [78]. One major challenge in cell-based engineering and regenerative medicine is 
to achieve large scale expansion of harvested cells without loss of multipotency. 
Prolonged expansion and extensive subculture has been shown to impair cellular 
function, leading to cellular senescence, which is associated with proliferation, arrest 
and apoptosis [79, 80].  
Although the standard protocol for maintaining BMSCs on feeder cells i.e. 
serum, is successful and widely adopted, such a serum-based culture protocol is labor 
intensive, prone to contamination from feeder cells, and difficult for high-throughput 
automation [81]. Thus, to facilitate the transition of a cell-based strategy tissue 
engineering approach, from basic studies to clinical application, the need has arisen to 
review the reagents used to expand stem cells [82]. One of the most important 
achievements in this area is the transition to xenogeneic-free medium.  
7.1.2.2 Cell seeding and cell seeding density  
Generation of engineered constructs starts with the attachment of isolated cells onto 
3D scaffolds. This is an essential procedure before in vivo implantation and plays a 
decisive role in the development of the engineered tissue [18]. Successful cell seeding 
depends on many factors, including uniform spatial distribution of cells throughout the 
scaffold volume and high cell survival rate [83]. Uniform cell distribution is important 
for uniform ECM protein and therefore well-organized tissue ingrowth [84]. For 
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instance, non-homogeneous seeding distribution results in increased tissue growth at 
the periphery of the scaffold with gradients in nutrient and metabolite concentrations 
throughout the scaffold [85, 86].  
Cell seeding efficiency can be increased either by optimizing cell seeding 
methods or by selecting scaffolds with suitable chemical and physical properties [18]. 
For the former, to date, a diversity of seeding techniques has been employed: static and 
dynamic methods and combinations of the two. For instance, dynamic cell seeding 
(e.g. using a perfusion bioreactor) has been shown to yield higher cell seeding 
efficiencies and more homogenous cell distribution than static cell seeding [87]. For the 
latter, the criteria and scaffold design are explored in tandem with properties such as 
biodegradability, porosity, interconnectivity, and mechanical integrity. It has been 
shown that various scaffold properties affect seeding efficiency. For example, more 
cells were predicted in the isotropic than in the gradient scaffold although both had a 
similar overall porosity and surface area [18, 88]. 
Scaffold surfaces can also be modified to enhance surface biological 
recognition sites for cells. For example, surface treatments of polymer scaffolds by 
alkaline hydrolysis, followed by oxygen plasma treatment, resulted in more cell 
infiltration than non-modified scaffolds [89]. The permeability of the scaffold in relation 
to scaffold geometry may be more important than the actual porosity and pore size, 
since it is more directly related to mass transport and fluid flow distribution throughout 
the scaffold [90].  
  One of the key elements related to cell seeding is the seeding density (number 
of cells per construct unit or volume). It is widely accepted that the cell seeding 
density of constructs is influenced by seeding efficiency and the spatial distribution [18, 
83, 91]. Cell seeding density is dependent on tissue type and culture conditions. A study 
in cartilage tissues has demonstrated that initial cell seeding density and nutrient 
accessibility through dynamic cell culture are important parameters in modulating the 
tissue development of engineered constructs [92]. With respect to regeneration of bone 
tissue, cell seeding density influences cellular events and tissue formation [69, 84, 91, 93-
95]. Compared with low cell seeding densities, high numbers of cells in a scaffold may 
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enhance cell seeding and spatial uniformity of cell distribution and/or cell morphology 
and alignment [84, 94, 96, 97]. It has been shown that an increase in cell seeding density 
from 1×106 cells/mL to 10×106 cells/mL results in homogenous cell distribution 
throughout the constructs, which might facilitate tissue development [98]. However, 
seeding efficiency and cell survival tend to decrease with increased cell seeding 
density, indicating saturation of the scaffold [87]. On the other hand, low cell seeding 
densities have been associated with limited cell proliferation and loss of mechanical 
integrity [99]. This has been attributed to loss of cell-cell contact and inadequate matrix 
production.  
Table I presents the results of published studies of in vivo cell seeding density,  
showing that no definite data about optimal cell seeding density are available, because 
of the diversity of the scaffold material and properties and the types of cells used in the 
various studies. One reason for this diversity could be the difficulty in measuring the 
surface area of scaffolds. However, with recent technological advances, it will be easy 
to calculate surface area and correlate this with the appropriate cell number. Moreover, 
with 3D printed scaffolds, the total surface area might be predetermined using 
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Table 1. In vivo preclinical studies involving BMSCs transplantation in bone 
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7.1.3 Cell-scaffold interactions  
Over the past few decades, numerous smart biomaterial platforms have been generated 
for biomedical applications. The interaction of cells with these biomaterials is critical 
for achieving functional engineered tissue [107]. Based primarily on its structure, a 
biomaterial will transmit specific signals to cells capable of decoding these into 
biochemical signals [108]. Therefore, fundamental to the conduct of studies of optimal 
biomedical applications is a concise understanding of the cell-biomaterial interaction,  
cell biology, and cell-extracellular matrix interactions [108]. 
When a scaffold is exposed to a biological environment (in vitro or in vivo), 
non-specific protein adsorption occurs. In this process, cells interact indirectly with the 
biomaterial surface through the layer of adsorbed proteins [107]. The adsorbed layer of 
protein is the substrate that recruits monocytes/macrophages and induces a number of 
reactions at the interface with the biomaterial [109]. These reactions will determine the 
degree of the biocompatibility of the material [109].  
Adverse responses to implantation of biomaterials in vivo include injury, cell-
biomaterial interactions, acute inflammation, chronic inflammation, granulation tissue 
development, foreign body reaction, and fibrosis/fibrous capsule development [110]. For 
instance, after implantation of polymeric constructs, fibrous encapsulation occurs and 
this may impair tissue regeneration [110]. Thus, the main goal in developing 
biomaterials suitable for tissue regeneration is to design an intelligent material that is 
able to integrate and interact with the surrounding tissues by biomolecular recognition 
[111]. By manipulating the design parameters of the biomaterial, the non-specific 
protein adsorption might be altered. This may make the biomaterial capable of 
eliciting specific cellular responses and directing new tissue formation [111].  
There are two theories explaining the mechanism of cell adhesion to a scaffold 
[112]. The first is the physicochemical theory: passive adhesion which includes electric, 
ionic, and hydrophobic interactions between cells and the protein layer. The second 
theory is the biological theory of active adhesion, characterized by the ability of cell 
membrane specific receptors to interact with specific ligands. These ligands may be 
situated on the ECM and interaction is mediated by integrin [112]. The integrin family 
comprises at least 24 distinct heterodimers which bind to specific amino acid 
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sequences such as the arginine–glycine–aspartic acid (RGD) recognition motif, present 
in many ECM proteins, including fibronectin and vitronectin [113, 114]. Alternatively, the 
ligands may be located on the membranes of neighboring cells, mediated by cadherin 
[112].  
While cellular recognition of a biomaterial “the bio-recognition process” is 
essentially based on integrin-mediated interactions, it also depends in particular on the 
chemical and physical properties of biomaterials [115]. For example, nanostructure 
materials are recognized as favorable biomaterials, not only because they increase the 
surface area of the material but also because they modify the surface topology without 
chemical alteration [116]. Therefore, cell-surface interactions through the adsorbed 
protein layer and its structure and nature determine the subsequent cellular events [117]. 
 
Figure 2. 3D microenvironment with three categories of cues that regulate cell-scaffold 
interaction and the engineered constructs (Modified and adapted from [118]) 
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Based on the understanding of cell-material interactions (Figure 2), different 
approaches can be used to achieve biomolecular recognition of materials, such as by 
introducing defined molecular recognition elements into biomaterials (e.g. integrin). A 
successful means of providing sites for integrin attachment in scaffolds is to include 
purified ECM proteins [119]. Another approach is to modulate the chemical composition 
and physical properties of the material surface, which has been shown to have a 
pronounced influence on cellular characteristics and activities (e.g. morphology, 
motility, and migration) [119]. The latter approach is the focus of the current thesis.   
7.1.4 Preparation of hydrophilic polymer scaffolds 
The selection of polymer materials for bone tissue engineering applications includes 
assessment of chemical stability, logistics issues, compatibility with sterilization 
techniques, mechanical performance, and the surface properties of the material [17, 22]. 
However, this does not necessarily ensure that the final surface properties of the 3D 
scaffold are optimal for cell-material interaction. Accordingly, it is often necessary to 
modify the surface properties of scaffold materials, without adversely changing the 
bulk properties.  
The ‘hydrophobic character’ and lack of natural recognition sites of polyester 
surfaces has restricted their application as scaffolding materials. In the absence of 
bioactive peptides RGD, cells interact with scaffolds by means of adsorbed protein, 
which depends on the physical and chemical properties of the surface [119]. The initial 
factor affecting protein adsorption may be hydrophilicity/hydrophobicity related to 
surface chemistry. Hydrophobic surfaces favor the adsorption of proteins from 
aqueous solutions thermodynamically [120]. However, this might induce irreversible 
adsorption and denature the protein’s native conformation and bioactivity [120]. 
Although it is recognized that surface wettability influences protein adsorption, its 
effect on cellular events is quite controversial [121-123]. It has been shown that compared 
with hydrophilic surfaces, hydrophobic surfaces might have a positive effect on cell 
attachment [121, 122]. On the other hand, improving surface hydrophilicity is necessary if 
hydrophobic materials are to support cell adherence, and particularly tissue ingrowth 
[123].  
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Hydrophilizing 3D porous scaffolds can improve not only cell-biomaterial 
interactions, but also the diffusion of cell culture medium and nutrient transfer into the 
scaffold, and therefore tissue ingrowth. Techniques to modify the polymer surface may 
be chemically and/or physically-based [124]. Chemically-based surface modifications 
are employed to change the surface chemistry of synthetic polymers by introducing 
new functional groups onto the scaffold polymer surfaces, or by coating the polymer 
with a thin layer of another polymer, or other chemical species,  such as material 
derived from HA [124, 125]. On the other hand, because of the importance of surface 
topography on cell behavior, a wide range of physical methods has been applied to 
modify the surface topography of scaffolds [126].  
Numerous techniques have been developed to improve the hydrophilicity of 
synthetic polymer scaffolds: 
a) Pre-wetting technique 
This is considered a simple procedure to achieve dense, uniform cell seeding into a 
hydrophobic polymer scaffold [127]. In brief, the hydrophobic porous polymer scaffold 
is pre-wet in alcohol (i.e. ethanol). The ethanol is then replaced with culture medium. 
This is in turn later replaced with cell-containing culture. This method was also used to 
sterilize scaffolds using 70% ethanol [21]. However, this is used as a temporary measure 
to achieve uniform cell seeding during initial cell culture: the inherent hydrophobic 
character of polymer surfaces is not changed [49].  
b) Bulk blending technique 
This technique is considered to be an easy way of improving the hydrophilicity of 
synthetic polymers. It involves mixing hydrophobic synthetic polymers, which provide 
the mechanical and construction properties of the scaffolds, with hydrophilic natural 
/synthetic polymers, which provide cell recognition sites [123, 128, 129]. The optimal 
hydrophilic polymer content in the scaffold is determined by balancing the cell affinity 
of the surface and the mechanical properties of the bulk scaffold [130]. Several 
hydrophilic natural/synthetic polymers and surfactants have been utilized to fabricate 
hydrophilized blended scaffolds, including collagen [131], dextran [130], silk fibroin [132], 
and poly(vinyl alcohol) [123]. However, this technique has some shortcomings, 
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including phase separation between hydrophilic and hydrophobic polymers and 
leaching out of hydrophilic polymers from the blend in an aqueous state [49].  
To overcome these drawbacks, copolymers have been blended with Tween 80 
as a simple means of adjusting the hydrophilicity of the polymers [128]. The interaction 
between the hydrophobic chain of Tween 80 and the main chain hydrophobic 
copolymer may prevent excessive extraction in aqueous conditions [129].  Tween 80 
contains a long hydrophobic chain (hydrophobic tail) and a water-soluble region 
comprising three hydrophilic polyethylene glycol (PEG) chains (hydrophilic head) 
with a total of 20 ethylene oxide units (Figure 3). This surfactant is widely used in 
parenteral and topical pharmaceutical formulations and is generally regarded as 
nontoxic and nonirritant [133]. It has been shown that Tween 80 may enhance the 
solubility of compounds, improving the absorption of drugs [134, 135]. Moreover, when 
compared with five different surfactants tested on human fibroblast cells, Tween 80 
showed the lowest cytotoxicity [136]. It functions as an antibacterial agent at 
concentrations demonstrated to be safe in humans [137].  
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c) Surface coating technique  
This physical adsorption technique aims to improve surface properties by coating 
hydrophilic components (e.g. polymer) onto surfaces of 3D porous synthetic 
biodegradable scaffolds. This technique is applicable to different scaffolds and 
implants and depends on surface properties (such as surface energy and surface 
charge), solvent interaction, and scaffold structure [124]. However, the instability of the 
interactions between the scaffold matrix and the applied hydrophilic polymer may be a 
drawback [138].  
Several methods are used to produce different types of coatings to functionalize 
the surface of the scaffolds. According to surface chemistry, these coatings can be 
categorized as inorganic, e.g. calcium phosphate [139, 140], organic, e.g. ECM-derived 
coatings [141] or alginate [142], or hybrid.  
It has been shown that nanoscale topography has a pronounced influence on 
biocompatibility and protein adsorption [143]. Recently, it was shown that 
nanocomposite materials offer favorable solutions as biomaterials, not only by 
increasing the surface area of the material but also by modifying the surface topology 
[116]. Of particular interest for biomedical applications is surface coating with nano-
diamond particles (nDPs) [144]. nDPs produced by detonation are one of the most 
promising materials for use in multifunctional nanocomposites to improve surface 
characteristics of biomaterials (e.g. polymers) [145-148]. The purified nDPs are composed 
of particles with an average diameter of ~ 5 nm. They contain an inert diamond core, 
covered by a layer of oxygen-containing functional groups such as hydroxyl (‒ OH), 
carboxylic acid (‒ COOH), etc (Figure 4). These are useful for tailoring the surface 
properties of polymer scaffolds, for instance hydrophilicity [149, 150] and surface 
functionalization with signal molecules (i.e. BMP2) [148].  
nDPs need to be dispersed as single particles to serve as nanofillers in 
polymeric scaffolds. The surface area of the nanoparticles accessible for interaction 
with the polymer matrix depends on the quality of filler dispersion. When adequately 
dispersed, nDPs increase the physical and mechanical properties of the 
nanocomposites [151]. Moreover, unpublished data from our laboratory show 
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enhancement of Teflon surface hydrophilicity in response to nDPs (reduction of 
contact angle from 119ᵒ in pristine Teflon to 10ᵒ when modified with nDPs).      
                                
Figure 4. Schematic model illustrating the structure of a single ~5-nm nanodiamond particle 
following oxidative purification. The diamond core is covered by a layer of surface functional 
groups (Figure adapted from [146]) 
 
d) Surface hydrolysis technique  
Hydrolysis of a polymer surface using strong acid (hydrochloric acid) or strong 
alkali such as sodium hydroxide or potassium hydroxide can be used to create –COOH 
and –OH groups on the surface, resulting in increased hydrophilicity [152]. It has been 
shown that treating a polymer surface with sodium hydroxide may improve 
hydrophilicity and increase cell seeding density [153]. This has been explained by 
hydrolysis of the ester group of polymer to –COOH and –OH groups. However, 
surface hydrolysis may alter the surface topography and bulk mechanical properties 
[154]. 
e) Plasma treatment technique 
Polymer surface modification using plasma treatment has been commonly employed to 
adjust surface adhesion and wetting properties by changing the chemical composition 
of the surface. The plasma is composed of highly excited atomic, molecular, ionic and 
radical species and is typically achieved when gases are excited into energetic states 
by radio frequency, microwave, or electrons from a hot filament discharge [155]. The 
aim is to introduce polarized groups (–COOH, –OH, –SO2, and –NH2) on polymer 
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surfaces using gaseous, metallic and laser-based plasma sources [155, 156]. However, 
some critical issues need to be addressed, such as the limited depth of penetration of 
plasma into the pores of 3D scaffold: this can lead to heterogeneous modification 
throughout the entire structure of the scaffolds and loss of surface modification over 
time (hydrophobic recovery) [157]. Thus, this method can be only used for 2D films or 
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8. Rationale for the Project  
In a cell-based approach to bone tissue engineering, the scaffold is central to success 
of the construct. Several studies have described implantation of a scaffold seeded with 
cultured osteogenic cells in treatment of human bone defects [12, 13, 158]. However, 
because the bone tissues comprise a complex biological system, the requirements of 
scaffold materials are very diverse [159]. Thus, many researchers from different 
scientific backgrounds have studied specific hypotheses related to bone tissue 
engineering, with special reference to such aspects as cells, biomaterials, design and 
fabrication of scaffolds, dynamic culture conditions, and cell-scaffolds interactions. 
 Several in vitro and in vivo studies have demonstrated excellent 
biocompatibility and new bone formation using poly(LLA-co-CL) scaffolds [46, 48, 149]. 
In the studies on which this thesis is based, poly(LLA-co-CL) was used as the scaffold 
material and was synthesized by random ring-opening polymerization [160]. Before 
seeding the scaffolds with BMSCs, it is important to ensure that the in vitro cell 
culture environment is carefully controlled with respect to the osteoblast-like cells. 
Several factors have been shown to influence cellular behavior and subsequent tissue 
regeneration, such as the addition of soluble factors to directly promote osteogenic 
differentiation, cell seeding related factors, the use of dynamic culture, and chemical 
and physical properties of the scaffold surface. Among these factors, cell seeding 
density may play a vital role in the fate of the seeded cells and must be optimized for 
specific scaffolding materials [91]. Moreover, the inconclusive and contradictory results 
using osteogenic supplements for BMSCs indicate the need for further investigation.  
After optimizing culture conditions, biocompatibility in terms of surface 
properties of these copolymer scaffolds should meet the requirements of a biomimetic 
bone scaffold. Unfortunately, one of the disadvantages of most synthetic degradable 
polymers is low biocompatibility due to inherent high surface hydrophobicity [161]. 
Thus, for the present series of studies, it was decided to modify the hydrophilicity of 
the poly(LLA-co-CL) scaffold surface by blending with Tween 80 and coating with 
nDPs. A previous study investigated the impact of modifying the hydrophilicity of 
poly(LLA-co-CL) with Tween 80 on the mechanical properties of the scaffolding and 
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the cellular response of human osteoblast-like cells [128]. The results demonstrated that 
a high concentration of Tween 80 increased the surface hydrophilicity but had a toxic 
effect on the cells and an adverse effect on the material properties of the scaffolds. 
Thus, further studies are indicated to determine the optimal concentration of Tween 80 
and then to test the biological responses both in vitro and in vivo.  
In addition to surface hydrophilicity, the influence of surface topography on 
BMSCs needs to be addressed. nDPs-BMSCs interactions have been studied under in 
vitro conditions, with specific reference to their application in bone regeneration [149]. 
An in vivo investigation is now required. There is very limited published data on this 
topic. Collectively, the research project on which this thesis is based was undertaken in 
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9. General Aim 
“If I have seen further than other, it is by standing upon shoulders of giants” 
Sir Isaac Newton 
A tissue engineering approach to repair of bone defects comprises the use of a 
biocompatible scaffolding material, seeded with cells capable of osteogenic activity to 
stimulate bone regeneration. Current research focuses on improvement, modification, 
and enhancement of biomaterials synthesized by increasing the hydrophilicity and 
osteoconductivity of the material. In the present project, a new generation of 
biodegradable biomaterials is being designed, to elicit specific cellular responses at the 
molecular level as well as at tissue level. This is based on molecular modifications of 
degradable polymer surfaces, which stimulate specific interactions with cells and 
thereby direct osteogenic cell differentiation. The overall purpose of this research 
project was to improve the physical and chemical properties of poly(LLA-co-CL) 
scaffolds to enhance biological responses. 
9.1 Specific aims: 
 To assess the influence of cell seeding density and the effect of osteogenic 
supplements on BMSC proliferation and differentiation.  (Paper I) 
 To evaluate the effect of cell seeding density with osteogenic supplements on 
bone regeneration. (Paper I) 
 To investigate whether enhancing the hydrophilicity of copolymer scaffolds 
affects albumin adsorption and seeding efficiency of BMSCs (Paper II and 
Paper III) 
 To evaluate ectopic bone formation by poly(LLA-co-CL) scaffolds seeded with 
BMSCs and blended with 3% Tween 80. (Paper II)   
 To assess osteogenic activity and bone regeneration of poly(LLA-co-CL) 
scaffolds modified with nDPs as a carrier for BMSCs using a rat calvarial 
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10. Materials and Methods  
10.1 Materials 
The materials, reagents, and their suppliers used in this project are presented in Table 1 
Table 2.  The materials and reagents used in all studies   
 
Material/Reagent Supplier Paper 
ε-Caprolactone CL, Sigma-Aldrich, Germany I - III 
L-Lactide LLA, Boehringer Ingelheim, Germany I - III 
Ethylene glycol Sigma-Aldrich, Germany I - III 
Stannous octoate Sn(Oct)2 Sigma-Aldrich, Germany I - III 
Sodium choloride (NaCl) Fluka Chemika, Germany I - III 
Minimum essential medium αMEM, InvitrogenTM, Carlsbad, California, USA I - III 
Fetal Bovine Serum HyClone™ , South Logan, Utah, USA I - III 
Antibiotic/Antimycotic HyClone™ South Logan, Utah, USA I - III 
Dexamethasone Sigma-Aldrich, Germany I - III 
β-Glycerophosphate Sigma-Aldrich, Germany I - III 
Ascorbic acid Sigma-Aldrich, Germany I - III 
Sevoflurane SevoFlo , Abbott Laboratories, UK I - III 
Tween 80 Polysorbate 80 HX2TM,  Ultra-Pure grade, Japan II 
MTT reagent Sigma, St Louis, MO, USA II 
Detonation diamond particles Gansu Lingyun Corp. Lanzhou, China III 
BCA Protein Assay Pierce™ protein assay, Thermo Fisher. III 
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10.2 Methods 
10.2.1 Polymerization (Papers I - III)  
Poly(LLA-co-CL) was synthesized by ring-opening polymerization (ROP) at 110°C 
for 72 h [160]. ε-Caprolactone was dried and purified. L-Lactide was recrystallized and 
dried before use. In the polymerization reaction, ethylene glycol was used as an 
initiator and stannous octoate (Sn(Oct)2) as the catalyst. The monomer to catalyst 
molar ratio was set to 10,000:1 to ensure low amounts of residual tin. The copolymer 
product was precipitated in cold hexane and methanol three times. 
10.2.2 Scaffold fabrication (Papers I - III)   
3D poly(LLA-co-CL) porous scaffolds were fabricated by a salt leaching technique as 
previously described [46]. Polymers were dissolved in chloroform. Sodium chloride to 
serve as the porogen was sieved; the ratio of polymer to porogen was set at 1:10. After 
the solvent had evaporated, scaffold samples were shaped to 10 mm (Ø) × 1.3 mm (δ) 
cylinders (for in vitro experiments) and 5 mm (Ø) × 1.3 mm (δ) (for in vivo 
experiments). 
10.2.3 Scaffold modification  
10.2.3.1 Poly(LLA-co-CL)/Tween 80 ( Paper II) 
Synthesized poly(LLA-co-CL) was blended with Tween 80 at ratios of 0.5%, 1%, and 
3% (w/w). Tween 80 was dissolved in chloroform, mixed with copolymer solutions 
and stirred overnight. To prepare 3D porous scaffolds, polymer blends with Tween 
80/NaCl (1:10 w/w) solutions were poured into Petri dishes [128].  
10.2.3.2 Nano-composite poly(LLA-co-CL) (Paper III) 
Acid purified detonation diamond particles were subjected to attrition milling as 
previously described [162] to achieve a narrow size distribution at ~ 5 nm particle 
diameter with low agglomeration of the nanodiamond particles. Poly(LLA-co-CL) 
scaffolds were modified with the nDPs (4% (w/v), i.e. 40 mg/ml) by a vacuum 
technique as previously described [148]. In brief, 0.5 ml nDPs solution and one scaffold 
were put into a glass beaker and perfused in vacuum. The vacuum chamber was 
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evacuated down to the pressure at which the nDP-water-solution changes into the 
vapour phase and the nDP burst into the scaffold surface. This cycle was repeated 10 
times. The nDPs modified poly(LLA-co-CL) scaffolds were rinsed in distilled water 
and vacuum dried.  
10.2.4 Characterization of scaffolds 
10.2.4.1 Nuclear magnetic resonance (1H NMR) (Papers I - III)   
1H NMR was used to analyze the monomer conversion. A Bruker Avance 400 NMR 
instrument (Bruker, Switzerland) was used [22]. The analysis was carried out at room 
temperature and samples were dissolved in deuteron-chloroform (CDCl3).  
10.2.4.2 Size exclusion chromatography (SEC) (Papers I - III)   
The molecular weights of all polymers were determined by the SEC system [22]. The 
molecular weights of the polymers used in the 3D porous scaffold samples were 
measured using the Verotech PL-GPC 50 (Polymer Laboratories, Varian Inc., MA, 
US) equipped with a refractive index detector and two Polar-Gel-M Organic GPC 
Columns (300 × 7.5 mm) from Varian Inc. Chloroform was used as the mobile phase. 
Narrow linear polystyrene standards were used for universal calibrations.  
10.2.4.3 Scanning electron microscopy (SEM) (Papers II and III)   
A SEM (Jeol JSM 7400F, Tokyo, Japan) was used to characterize the microstructure 
of the scaffolds. All scaffolds were coated with gold (Cressington Sputter Coater). The 
analysis was performed at an accelerating voltage of 10 kV and magnifications up to 
40000 X.  
10.2.4.4 Micro-computed tomography (μ-CT) (Papers II and III) 
μ-CT was carried out in SkyScan model 1172 (Kontich, Belgium). μ-CT was used to 
determine the pore structure of the scaffolds (porosity, pore size, surface area, and pore 
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10.2.4.5 Water contact angle (Paper II) 
Static contact angle measurements were made in CAM 200 contact angle system (KSV 
Instruments Ltd., Helsinki, Finland). A drop of 5 μL Milli-Q water was placed onto the 
surface of film samples and contact angles were recorded by analyzing frames 
captured using an optical camera. Recorded frames were evaluated by CAM 2008 
software (version 4.0, KSV) to calculate contact angles. Average values were 
calculated from five independent measurements [128].  
10.2.4.6 The protein adsorption measurement (Papers II and III) 
The protein adsorption of pristine and modified poly(LLA-co-CL) scaffolds was 
assessed as previously described [163]. Samples were incubated in PBS for 4 h, and then 
incubated in 10 mg/mL BSA at 37 ᵒ C for 2 h. The samples were rinsed twice with 
PBS. The samples were then treated overnight with 1% sodium dodecyl sulfate (SDS), 
to remove protein adsorbed to the surface. The amounts of adsorbed protein were 
quantified using a Pierce™ BCA protein assay kit. 
10.2.5 Cell culture 
10.2.5.1 Cell isolation (Papers I - III) 
BMSCs were isolated from the femurs of donor Lewis male rats [164]. In brief, the rats 
were housed under uniform conditions, and euthanized by carbon dioxide (CO2) 
inhalation. The metaphyseal ends of the femurs were cut off, and the marrow cavity 
was flushed with minimum essential medium (αMEM) supplemented with 1% 
antibiotic/antimycotic (AB) and 15 % fetal bovine serum (FBS) into a sterile falcon 
tube. The cells were centrifuged and cultured in fresh α-MEM medium containing 
15% FBS and plated in culture flasks (NUNC A/S, Roskilde, Denmark). The medium 
was changed the next day, with fresh αMEM medium containing 1% PS and 10% 
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10.2.5.2 Expansion (Papers I - III) 
The cells were cultured in αMEM only, supplemented with 1% AB and 10 % FBS 
(Paper I). Osteogenic supplements were added to the culture medium (0.05 mM 
ascorbic acid, 10 mMb-glycerophosphate, and100 nM dexamethasone (dex)) [69, 165] 7 
days before the experiments (Papers I - III). 
10.2.6 Sterilization (Papers I - III) 
The 3D scaffolds used in these studies were sterilized by irradiation with electron 
beam radiation (25 kGy dose), created by a pulsed electron accelerator (Mikrotron, 
Acceleratorteknik, Stockholm, Sweden) at 6.5 MeV [22]. 
10.2.7 Seeding efficiency (Papers II and III) 
In order to determine seeding efficiency [166], pristine and modified scaffolds were 
placed into 96-well plates and soaked with the culture medium overnight. Thereafter, 
the cells were seeded directly onto the scaffolds, at a concentration of 5 × 105 
cells/scaffold, and incubated for 3h, to allow adequate time for seeding. The scaffolds 
were then removed and the cells remaining in the wells were counted using automated 
cell counters (Countess™, Invitrogen, Life Technologies, USA). The seeding efficiency 
was calculated using the following equation: 
             Seeding efficiency (%)    
 
10.2.8 Graft preparation (Papers I - III)  
3D porous scaffolds were pre-wet with the culture medium in an incubator at 37 ᵒC and 
5% CO2 overnight. The BMSCs were then seeded into the various scaffolds, placed at 
the bottom of wells in 96-well plates, at a density of 1 × 106 cells/scaffold (Paper I) 
and 2 × 106 cells/scaffold (Papers I-III). An orbital shaker (EppendorfVR, Hamburg, 
Germany) was used for 5 minutes at 1000 rpm to facilitate cell distribution within each 
scaffold [167].  
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10.2.9 Bioreactors  
To improve in vitro culture conditions, bioreactor systems have been widely used for 
tissue engineering applications. Compared with static cultures, dynamic cell cultures 
increase medium perfusion: this might enhance nutrient delivery as well as mechanical 
stimulation of cells [168]. Spinner flasks, rotating wall bioreactors, and perfusion 
systems have all been tested. Each system has been shown to be effective [169].  
10.2.9.1 Spinner flask bioreactors (Paper I) 
In a simple bioreactor, scaffolds were suspended from the lid of a flask, and a stir bar 
was used to induce a convection current in the medium surrounding the scaffolds 
(Figure 6) [169]. The dynamic culture system was constructed using four modified 
spinner flasks (purchased from Belleco Glass; Figure 6) inside a 37 °C incubator with 
a humidified 5 % CO2 atmosphere. This system was used to incubate BMSCs for up to 
21 days. The original driver paddle in the flasks was replaced by a metal component 
with holders for scaffold fixation and equipped with a magnetic stir bar to control the 
rotation speed [165].   
 
Figure 6. Spinner flask bioreactor. Scaffolds are suspended in the medium and the medium 
is stirred with a magnetic stirrer, to improve nutrient delivery to the scaffold 
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10.2.9.2 Biaxial rotating bioreactor (BXR) (Paper II) 
The BXR bioreactor consists of a spherical culture chamber, where the cellular 
scaffolds are anchored to the cap of the bioreactor with pins, a medium reservoir and a 
perfusion system, which connects the culture chamber and the medium reservoir, as 
previously described [170]. The spherical culture chamber is designed to rotate on two 
perpendicular axes (Y and Z). The bioreactor systems were placed in an incubator 
during the culture period (Figure 7). 
 
Figure 7. Biaxial rotating bioreactor (BXR): The bioreactor system consisted of a spherical 
culture vessel (volume 500 ml) connected to the medium reservoir through tubing in which a 
perfusion flow is generated. The spherical vessel sits on an articulator which allows rotation 
in two perpendicular axes, as shown in A and B (X and Z). 
10.2.10 In vitro experiments  
10.2.10.1 SEM (Paper I) 
Samples were placed in 2.5% glutaraldehyde α-MEM without serum and fixed for 30 
min at room temperature. The samples were then fixed in 2.5% glutaraldehyde in 0.1M 
Na-cacodylate pH 7.2 with 0.1M sucrose for 30 minutes at room temperature. The 
samples were then treated with 1% osmium tetroxide in distilled water for 1 h, 
followed by dehydration through a graded series of ethanol solutions, critical point 
dried and sputter coated with a 10 nm conducting layer of gold platinum. Finally, the 
specimens were examined by SEM (Jeol JSM 7400F, Tokyo, Japan), using a voltage 
of 10 kV. Cell adhesion and spreading on the scaffolds were documented. 
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10.2.10.2. DNA quantification of cell proliferation (Paper I)  
DNA quantification was conducted using reagents from the MasterPure™ Complete 
DNA and RNA Purification Kit (Epicentre® Biotechnologies, Madison, Wisconsin, 
USA) [171]. The amount and purity of DNA per scaffold were measured by optical 
densitometry at 260 and 280 nm, using a Nanodrop ND 1000 spectrophotometer 
(NanoDrop Technologies, Wilmington, Delaware, USA). 
10.2.10.3 Cell proliferation assay (Paper II)  
Methyl Thiazlol Tetrazolium (MTT) assay, measuring mitochondrial metabolic 
activity was used to assess cell proliferation [48]. This colorimetric assay is based on the 
ability of living cells to reduce the yellow reagent MTT to a purple formazan product. 
Briefly, scaffolds were transferred into 96-well plates and washed with PBS. MTT 
reagents were added to each sample and incubated for 4 hours in the dark at 37°C, 
under a CO2 (5%) atmosphere. The MTT was aspirated and the formazan product was 
solubilized in 0.2 mL DMSO containing 6.25% (v/v) 0.1M NaOH. The resultant 
absorbance was measured at 570 nm, using a microplate reader (BMG LABTECH, 
GmbH, Germany). 
10.2.10.4 Real-time reverse transcription-polymerase chain reaction analysis (RT-
PCR) (Papers I and II) 
RNA isolation and RT- PCR were carried out as described previously [165]. Briefly, 
total RNA was collected from cells grown onto the scaffolds using an isolation kit 
(E.Z.N.AVR, Omega Bio-Tek, Norcross, Georgia, USA) according to the 
manufacturer’s protocol. RNA purity and quantification were determined by 
spectrophotometry (NanoDrop Spectrophotometer, NanoDrop Technologies). Real-
time reverse transcription-polymerase chain reaction (RT-PCR) was conducted under 
standard enzyme and cycling conditions on a StepOneTM real-time PCR system, using 
TaqManVR gene expression assays (Applied BiosystemsTM, Carlsbad, California, 
USA). The data were analyzed using a comparative Ct method by StepOne. 
Expression levels of the genes were normalized to the Housekeeper index with 
GAPDH serving as the endogenous control.  
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10.2.10.5 Chemical analysis of hydrophilic scaffolds (Paper II) 
1H NMR was used to analyze Tween 80 composition remaining in the scaffolds up to 
21 days. A Bruker Avance 400 NMR instrument (Bruker, Switzerland) was used. The 
analysis was carried out at room temperature and samples were dissolved in deuteron-
chloroform (CDCl3). Change in scaffold Mn was determined using the SEC system, up 
to 21 days.  
10.2.11 Animal models 
The development of bioengineered bone scaffolds is a stepwise process which starts 
with a crucial in vitro optimization step, comprising assessment of scaffold 
parameters, such as scaffold material and design, cellular events on the biomaterial 
surface, and osteoconductivity and osteoinductivity. The next step is conducted in an 
in vivo environment, usually in an animal model, before eventually proceeding to 
human clinical trials.   
10.2.11.1 Scaffold-related criteria for appropriate choice of animal model in bone 
tissue engineering  
In bone tissue engineering, animal models are used to evaluate the bone regeneration 
process and the bone–biomaterial interactions. Physiological or pathological evidence 
of modulation of the ossification pathway can also be assessed [172]. The size, nature 
(e.g. granular or injectable), hardness, and chemical composition of the scaffolds are 
the parameters which have to be considered when selecting the appropriate the animal 
species (small vs. large animals), the anatomical site (endochondral vs 
intramembranous bone) and site (load-bearing vs. non-load-bearing). Depending on 
proximity to the autologous bone tissue, in vivo models can be classified into 
heterotopic or ectopic (bone is formed at an abnormal anatomical site, usually in soft 
tissue) or orthotopic (bone is formed at its normal anatomical site).  
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10.2.11.2 Assessment of biofunctionality of pristine and modified poly(LLA-co-CL) 
scaffolds 
10.2.11.2.1 Orthotopic bone formation (Papers I and III) 
The rat calvarial model is the gold standard for orthotopic implantation studies (Figure 
8). The orthotopic implantation method allows assessments of osteoconductivity and 
osteointegration of the pristine and modified poly(LLA-co-CL) scaffolds [173]. Because 
calvaria have poor blood supply and relatively little bone marrow, achieving bone 
regeneration is a challenge.  
Using a custom-made mask, the rats were anesthetized with isofluorane (Isoba 
vetVR, Schering Plough, Kenilworth, NJ, USA) in combination with O2. A full-
thickness defect (5 mm in diameter) was created in the central area of each parietal 
bone. The dura mater was left undisturbed. The skin was repositioned and stabilized 
with sutures (Vicryl Plus 4-0). All animals were given an intramuscular dose of 
Buprenorphine (Temgesic® 0.3 mg\kg) as an analgesic and allowed to recover. The 
status of the surgical wound, signs of infection, food intake, and activity were 
monitored daily.       
 
Figure 8. Lewis rat calvarial defect. (A) The bone was exposed and the defect created by 
incision and retraction of the skin and periosteum. (B) Poly(LLA-c-oCL) scaffolds, pristine or 
modified, were insterted into the defects.  
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10.2.11.2.2 Ectopic bone formation (Paper II) 
Heterotopic implantation is the gold standard for testing both the biocompatibility and 
the osteoconductive potential of constructs in vivo. Poly(LLA-co-CL) scaffolds 
modified with Tween 80 were implanted subcutaneously into Lewis male rats to 
evaluate the biocompatibility of the modified material (Figure 9).  
The rats were anesthetized with isofluorane (Isoba vetVR, Schering Plough, 
Kenilworth, NJ, USA) in combination with O2. Using blunt dissection, a pocket was 
created on both sides of an incision and one cell/scaffold construct was inserted into 
each pocket. All animals were given an intramuscular dose of Buprenorphine 
(Temgesic® 0.3 mg\kg) as an analgesic and allowed to recover. The status of the 
surgical wound, signs of infection, food intake, and activity were monitored daily.   
 
Figure 9. Subcutaneous implantation of scaffolds in to Lewis rats, (A) shaving, (B) skin 
incision on the dorsal aspect, and (C) closure of the incision. 
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10.2.12 In vivo evaluation 
10.2.12.1 Positron emission tomography/computed tomography PET/CT (Paper III) 
PET/CT scanning with 18F-Sodium Fluoride (18F-NaF) provides information on bone 
formation. Fluoride is metabolised into the bone mineral by exchanging with hydroxyl 
groups on hydroxyapatite to form fluoroapatite, which can be used to produce 
quantitative images which correlate with new bone formation [174]. The development of 
a rat imaging system integrating PET with x-ray computed tomography allowed  
simultaneous anatomic and molecular imaging in vivo, for precise measurements of 
bone-forming activity [175]. Clinical application of bone scanning with [18]F-NaF was 
first described in 1993 [176]. It provides highly sensitive, 3D tomographic images, and 
hybrid PET/CT imaging of the skeleton, with , high spatial resolution, and attenuation 
correction [175].  
For PET/CT scanning (Figure 10), the rats were anesthetized with sevoflurane 
(Sevoflo®, Abbott, Illinois, USA). 18F-NaF data were acquired from a PET/CT scanner 
(Mediso Medical Imaging System, Budapest, Hungary). PET emission scans were 
acquired for 10 min just after injection of 18F-NaF, followed by CT acquisitions for 
anatomic correlation. Nucline software (Mediso Medical Imaging System, Budapest, 
Hungary) was used for PET data reconstruction, with correction for attenuation based 
on CT data. Inter View Fusion software (Mediso) was used for co-registration of PET 
and CT data, quantification of standard uptake values in an area of interest, and three 
dimensional visualization.  
 




Figure 10. Anaesthetized rat on PET/CT scanner bed in supine position after injection of 18F-
NaF. 
10.2.13 Ex vivo evaluation 
10.2.13.1 μ-CT (Papers I - III) 
For quantitative evaluation of new bone formation in the rat calvarial defects or 
subcutaneous implants μ-CT scans were taken using the SkyScan1172VR X-ray system 
(SkyScanVR, Kontich, Belgium) with the CTAn 1.8VR and NRECON 
RECONSTRUCTIONVR CT software (SkyScanVR), as previously described [177]. A 
0.5-mm aluminum filter was used to optimize the images. Source voltage and current 
were set at 50 kV and 200 μA, respectively. After applying CTAn 1.8VR to each 
reconstructed BMP file, Bone volume (BV), Tissue volume (TV) and Bone 
volume/Tissue volume (BV/TV) values were obtained.  
10.2.13.2 Histology (Papers I - III)   
Specimens for histological examination were fixed with 4% paraformaldehyde 
(Merck, White House Station, NJ, USA) and decalcified, using 10% 
ethylenediaminetetraacetic acid (EDTA) in 0.1M Tris buffer and 7.5% 
polyvinylpyrrolidone (PVP) (Merck). The specimens were then washed in PBS, 
embedded in paraffin and serially sectioned using a microtome (HM 325, Thermo 
Scientific). The sections, 4–6 μm thick, were mounted on glass slides, deparaffinized, 
 
UiB | 10. Materials and Methods 43 
 
hydrated by the application of xylene and alcohol in series and stained with 
Hematoxylin and eosin (H&E) and Masson’s Trichrome (MT) stains. 
10.2.14 Statistics  
i. Paper I  
For accurate data of the hierarchical structure of the outcome variables, a multilevel 
modelling analysis was applied. For the PCR statistical analyses, reference values 
were first calculated for all the expression measures. A random effect model with each 
particular gene as the random factor (to control for the two repeated measures for each 
gene) was applied. The reference value was defined as the predicted mean from these 
models. ΔCt values for each gene were thereafter calculated as the difference between 
the gene measures and the reference values. The ΔΔCt values for all the expressions 
were then analyzed in linear models using robust variance estimates to control for the 
repeated measures for each particular gene. Mean values, standard deviations and 95 
% confidence intervals were estimated from these models. The effects were tested 
hierarchically. First the main effects of seeding density, osteogenic medium and days 
were tested. Thereafter a model including the first order interaction was applied 
(densities*medium, medium*days, density*days), followed by a model including the 
second order interaction (densities*medium*days). The μ-CT observations were 
measured at only one time point. This analytic approach will correspond with repeated 
measures analyses of variance. The statistical package StataIC version 13 was used to 
analyze the data. P-values less than 0.05 were considered statistically significant. 
ii. Paper II 
Fourteen scaffolds from each group were available for the statistical analysis in vitro 
and 14 rats were included in the in vivo analysis. To provide accurate data on the 
hierarchical structure of the outcome variables, a multilevel modelling analysis was 
applied. For proliferation assays, fours scaffold replicates were repeated in triplicate 
for all experiments. One-way analysis of variance (ANOVA) was used to test the 
effect of the different Tween 80 concentrations on cell proliferation. For PCR, 
reference values for different gene expressions for each rat were calculated using 
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mixed effects models. ΔCt values were calculated as the gene expression minus the 
calculated reference values. Next, a general linear model, with robust variance 
estimators adjusted for data clustering within rats, was applied. The results expressed 
mean differences for the ΔΔCt values and were presented as xFold-values. For 
quantitative analysis of bone formation (mean ± standard errors), Student t-test was 
used to compare pristine and modified scaffolds. Stata version 13 (Texas, USA) was 
applied. P-values less than 0.05 (5 %) were considered statistically significant. 
iii. Paper III 
A two-tail Student’s t-test (assuming equal variances) was applied to determine the 
statistical significance of the differences in microstructure parameters of scaffolds, 
protein adsorption, SUVmean, and SUVmax. To compare bone volume (BV) and 
percentages of bone volume and tissue volume (BV/TV) between poly(LLA-co-CL), 
poly(LLA-co-CL)/nDP with cells, adjusting for the repeated measures for each rat, a 
linear mixed model was used. The results from the model were reported as mean 
differences. StataIC version 14 (Tx, USA) was used for the analyses. 
10.3 Ethical approval  
All animal experiments were approved by the Norwegian Animal Research Authority 
and conducted according to the European Convention for the Protection of Vertebrates 
Used for Scientific Purposes (local approval numbers 20124903, 20142029 and 
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11. Main Results and Discussion  
In tissue engineering, the cell-scaffold interaction is a major determinant of success. 
The surface properties of the scaffolding influence the growth and function of the 
seeded cells. A disadvantage of many synthetic degradable polymers for application as 
scaffolding material is poor bioactivity, due to surface hydrophobicity [178]. 
Hydrophobic porous scaffolds tend to float in cell culture medium and most of the 
pores remain empty [49]. This in turn may influence the homogeneous cellularity of the 
engineered constructs.  
The effect of surface wettability on the efficiency, viability, and uniformity of 
cells attached to scaffolds has been investigated in a number of studies [123, 132, 152], 
showing good proliferation and differentiation of cells seeded onto hydrophilic 
surfaces. Surface wettability may also influence the morphological and compositional 
properties of the engineered constructs. It is defined as the interaction between fluid 
and solid. The contact angle, measured through water droplet on a surface, is an 
indicator of surface wettability: the less the angle, the more hydrophilic the surface 
[179]. The preferred range of surface wettability varies, depending on cell type. For 
instance, adhesion of osteoblasts is reported to decrease when the contact angle 
increases from 0° to 106° [180]. Maximum adhesion of fibroblasts occurs at contact 
angles between 60° and 80° [181].  
However, the contact angles of hydrophobic degradable polymers lie outside 
the preferred range for optimal cellular behavior, hence the need for modification [182].  
Despite other positive properties of PCL as a scaffolding material for tissue 
engineering applications, it is hydrophobic, with a water contact angle of around 123°. 
Coating with poly(vinyl phosphonic acid-co-acrylic acid) can convert PCL to a 
hydrophilic material, with a water contact angle of 43° [183]. In this study in which 
surface hydrophilicity was improved by coating the scaffolds, in vitro culture of 
osteoblasts for up to 14 days resulted in a better defined cytoskeleton, indicating better 
spreading of cells [183]. In another study, MSCs seeded onto a modified hydrophilic 
surface (contact angle θ = 57°) exhibited accelerated proliferation and neurogenic 
differentiation compared with cells seeded onto unmodified surfaces [184].  
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Thus, the main focus of the present series of studies was to achieve uniform 
distribution of BMSCs onto poly(LLA-co-CL) scaffolds, by modifying the 
hydrophilicity of the scaffolding surface. An initial study (Paper I) was undertaken to 
optimize the culture conditions for BMSCs seeded onto poly(LLA-co-CL) scaffolds:   
the outcomes were evaluated in vitro and then in vivo, using a rat calvarial defect 
model. Two techniques for modifying the surface properties of scaffolds were then 
investigated: in Paper II, copolymer was blended with Tween 80 and in Paper III, 
copolymer scaffolds were coated with nDPs. In Paper II, the promising in vitro results 
were followed by an in vivo experiment using a subcutaneous rat model. Similarly, in 
Paper III, the successful in vitro experiment was followed by an in vivo experiment, 
using a critical size rat calvarial defect. Thus, the studies comprised investigation not 
only of different approaches to modifying the surface properties of the scaffolding 
material, but also evaluation of the response of the modified scaffolds in in vivo 
models of orthotopic or ectopic bone formation.  
11.1 Optimizing culture conditions for BMSCs 
BMSCs have an essential role in the maintenance of bone turnover throughout life and 
can be a source of adult stem cells [185]. These are the cells most widely used in 
(pre)clinical bone tissue engineering studies [10-13, 186, 187]. Bone marrow contains a very 
low percentage of mesenchymal stem cells (one per 100,000 mono-nucleated cells), 
and several studies have shown that in order to form bone tissue, in vitro expansion of 
the stem cells is necessary to ensure an adequate volume for seeding into the scaffolds 
[188]. In a previous study, BMSCs were first expanded in vitro to increase the number 
of osteoprogenitor cells, then seeded onto scaffolds, and finally implanted into 
clinically critical defects, to achieve bone regeneration [189].  
A bone formative experimental system, using BMSCs derived from rats, was 
first described by Maniatopuoulas et al [164]. The cells were characterized 
morphologically, immunohistologically, and biochemically [164]. In the present studies, 
isolation of BMSCs (Papers I - III) was based on the capacity for plastic attachment 
under standard culture conditions. Colonies of fibroblast-like cells (50 - 60 
cells/colony) attached to the plastic were visualized on day 4 (Figure 11A) after 
 
UiB | 11. Main Results and Discussion 47 
 
seeding. BMSCs exhibited characteristic spindle shapes and polygonal morphology. 
Moreover, distinct proliferative properties were observed and only a few days after 
passaging the cells reached about 80 - 90% confluence (Figure 11B). Viability was 
around 90%.  
 
Figure 11. Morphology of BMSCs in vitro. Primary cells after culture (A) for 4 days and (B) 
after 10 days of culturing, showing 80-90% confluence. 
 
11.1.1 Maturation stages of BMSCs as key determinants in induction of new bone 
tissue  
During culture and passage, the ability of BMSCs to differentiate into osteoblast-like 
cells is easily disturbed [190]. Thus, it is important that BMSCs are appropriately 
cultured, expanded, and induced into osteogenic cells [190]. It is somewhat surprising 
that although numerous studies using BMSCs have been published, there is no 
established and widely accepted cell expansion (culture/induction) protocol. Thus, an 
important issue is to establish optimal culture protocols for BMSCs seeded into 
poly(LLA-co-CL) scaffolding using in vitro and in vivo models.  
Mineral deposition has been observed when BMSCs are cultured and expanded 
in culture medium supplemented with dexamethasone, L-ascorbic acid, and β-
glycerophosphate, denoting that BMSCs are able to differentiate into osteoblasts [191]. 
At a very early stage of osteoblastic differentiation, BMSCs have a high proliferation 
rate, allowing them to increase in number following implantation [191]. This concept is 
supported by the results of Paper I, showing a significant overall positive effect on the 
quantity of DNA in BMSCs treated with osteogenic supplements.  
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Osteogenic supplements were also associated with significant enhancement of 
osteogenesis and bone formation in rat cranial defects. Thus, BMSCs were committed 
to osteoblastic differentiation after exposure to osteogenic medium. Full maturation of 
these cells might have occurred in the defect site, followed by ECM deposition, which 
in turn could enhance recruitment of new osteo-progenitor cells from the host. These 
findings are in accordance with previous studies in which scaffolds, seeded with MSCs 
pre-cultured with osteogenic supplements, showed an increase in bone formation [191, 
192]. On the other hand, it has been reported that when MSCs fully differentiate, 
pluripotency and immunosuppressibility decrease and this may result in rejection of 
xenogeneic and allogeneic transplantation, jeopardizing the viability of MSCs and 
leading to compromised osteogenicity [193]. In a previous study intended to evaluate 
whether MSCs in cultures retain immunomodulating properties in vivo following 
intravenous or local allotransplantation, MSCs were strongly immunosuppressive in 
vitro, but this immunosuppressive response was reduced in vivo because they were 
recognized and rejected by the host [193]. Therefore, the implanted MSCs should be at a 
certain stage of maturation. 
The effect of osteogenic supplements might be influenced by the tissues from 
which the stem cells were isolated: cells of different origin may have inherited 
different degrees of osteogenicity [194-196]. It has been reported that MSCs originating 
from adipose tissue demonstrate a significant increase in osteogenesis when pre-
treated with osteogenic supplements, whereas MSCs from umbilical cord blood 
undergo a significant decrease in osteogenicity [196]. In another study, in 22 out of 24 
donors, BMSC strains propagated with and without osteogenic supplements formed 
similar amounts of bone in vivo [197]. In contrast, it has recently been proposed that an 
ideal scaffold for bone tissue engineering should be able to trigger and continuously 
support the MSCs commitment towards osteoblast-like cells, avoiding the need to 
expose the cells to osteogenic supplements [198]. These contradictory results could be 
attributable to lack of consistency in the design of the studies, such as variations in 
concentrations of osteogenic supplements, the duration of treatment, and the timing of 
supplementation, with negative consequences for osteogenesis [199].  
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11.1.2 Cell seeding density may promote bone formation 
Because of heterogeneity in cell types and scaffold materials, there are no published 
studies on optimal cell seeding density. However, there is consensus that a certain 
threshold of cell density is essential to achieve successful in vivo bone regeneration 
[93]. Initial seeding density can alter the proliferation as well as the expression of 
osteogenic genes by affecting the distance of signals among cells [84]. Thus, in the 
present studies, it was essential to determine the influence of cell seeding density on 
cell proliferation and differentiation of BMSCs. In Paper I, high and low cell seeding 
densities were used: 1 × 106 cells/scaffold and 2 × 106 cells/scaffold respectively, in 
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Figure 12. mRNA expression of by qRT-PCR, presented as x-fold changes relative to the 
expression of the mean of the calibrator sample LD-OM. Figure 11.A. Runx2 expression is 
downregulated by osteogenic medium (p=0.005) and upregulated by high cell seeding density 
(p=0.001). Figure 11.B. Col1 expression is upregulated by high cell seeding density 
(p=0.001). Figure 11.C. ALP expression, disclosing a significant relationship between high 
cell density, osteogenic medium and number of days (p=0.026). Figure 11.D. BMP2 
expression is upregulated by osteogenic medium (p<0.001) and high cell seeding density 
(p=0.003).  Figure 11.E. BSP expression is upregulated by osteogenic medium (p<0.001) and 
high cell seeding density (p=0.033). Figure 3F. OC expression is upregulated by osteogenic 
medium (p=0.002) and high cell seeding density (p=0.013).   
 
The in vitro data generated in Paper I confirmed the influence of seeding 
density of BMSCs on cell proliferation. DNA assay was used to assess proliferation: 
high cell seeding density significantly stimulated the amount of DNA detected. Cell 
proliferation is strongly regulated by (1) surface area available for attachment and (2) 
contact-inhibition between adjacent cells [84, 91]. The porosity of 3D porous scaffolds 
used in the current series of experiments (Papers I - III) exceeds 85%, providing a 
large surface area for cellular events, conducive to uniform cell distribution [200-202]. 
The extent of cell-cell interactions may be controlled by the density of seeded cells.  
The effect of cell seeding density on the osteogenic differentiation of BMSCs 
was monitored for up to 21 days. High seeding density led to significantly upregulated 
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expression of osteogenic markers, suggesting that high seeding density is associated 
with more efficient differentiation of BMSCs. As shown in Figure 12, numerous 
genes are expressed at high levels during distinct stages of differentiation, e.g. alkaline 
phosphatase (ALP), type-I collagen, bone sialoprotein, and osteocalcin (OC) [203]. 
ALP, an early marker for osteoblasts [204], was first upregulated at 7 days and then 
downregulated at 21 days. In contrast, OC a late marker of osteoblast maturation [205], 
plays a vital role in osteogenesis and was first upregulated at 21 days. This is 
accordance with a previous report showing that increased cell numbers in the presence 
of osteogenic supplements, were associated with upregulated osteocalcin expression 
and maturation of osteoblasts [84]. There may be a correlation between increased 
extracellular protein secretion and increased number of mature osteoblasts, leading to 
promotion of bone formation.  
The in vitro results of Paper I indicate that the three distinct stages of 
osteoblastic phenotype development are sensitive to cell seeding density. According to 
a previous report [203], the first stage of osteogenic progenitor cell growth is highly 
proliferative, with formation of extracellular matrix. The second stage shows matrix 
maturation, with decreased cell proliferation and upregulated ALP expression, a 
sequence of events also seen in the present study [203]. The final stage comprises 
mineralization by expression of OC. At all these stages, high cell seeding density had a 
significant impact: enhanced cellular proliferation, upregulated expression of ALP and 
OC (early and late osteogenic markers). Our results suggest that cell seeding density 
promotes osteogenic differentiation in an in vitro environment.  
There is a need for in vivo testing of cell seeding density, in order to confirm 
consistency between in vitro and in vivo microenvironments. There is lack of 
consistency in the results of published studies [84, 94, 96, 97]. One report suggests that low 
seeding densities can prolong the time needed to achieve a well-populated scaffold, 
ready for implantation, and may compromise cellular contact and hence influence bone 
formation [69]. However, high cell seeding densities do not necessarily benefit cell 
behavior because overloading may result in limited nutrient transport and insufficient 
waste removal from the internal structures [69].  
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In the present studies, the in vitro and in vivo findings were in good agreement: 
high cell seeding density promoted bone formation in the calvarial defects (Figure 
13). Doubling the number of cells from 1 × 106 per scaffold to 2 × 106 resulted in a 
significant increase in bone formation.  
In general, a certain threshold (i.e., the optimal cell density) is required to 
enhance osteogenic marker expression and extracellular matrix production (i.e., 
mineralization). In a previous study the same seeding density was used to grow the 
MSCs onto biphasic calcium phosphate granules and was found to promote formation 
of a mature bone organ [206]. It cannot be assumed that a further increase in cell seeding 
density would lead to more bone formation: a previous study has shown that doubling 
cell density did not yield significantly more bone [206].  
 
 
Figure 13. Quantification of percentage of area and volume of bone regeneration in 
calvarial defects after 8 weeks of healing. Implantation of scaffolds containing cells seeded at 
high density and cultured with osteogenic medium exhibit a significant percentage of bone 
volume (p=0.038). 
Collectively, the findings of Paper I demonstrated a synergistic stimulation of 
cell seeding density and osteogenic supplements on bone regeneration. The initial 
seeding density clearly influenced cellular events and the resulting bone formation. 
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However, the stage of cell maturation and differentiation warrant further in depth 
investigation.  
11.2 Hydrophilic copolymer scaffolding as a carrier for BMSCs   
After optimizing culture conditions and seeding density of BMSCs in 3D porous 
poly(LLA-co-CL) scaffolds, the hydrophilicity of the scaffolds was modified either 
with Tween 80 (Paper II) or nanodiamond particles (Paper III).  
11.2.1 Enhanced seeding efficiency of BMSCs onto hydrophilic copolymer 
scaffolds   
Cell seeding efficiency is a major determinant of successful engineering and is 
governed mainly by the surface properties of the scaffold and the architecture of the 
porous structure [166]. The increase in seeding efficiency in poly(LLA-co-CL) scaffolds 
modified with 3% Tween 80 was 23% (unpublished complementary data) and 14% in 
those modified with nDPs (Paper III) (Figure 14). 
 
Figure 14. Seeding efficiency for each type of scaffold. There was a significant increase in 
the seeding efficiency of BMSCs seeded into modified poly(LLA-co-CL). (* P ≤ 0.05 and ** 
P ≤ 0.01) 
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The hydrophilicity of the copolymer scaffold surface promoted the attachment 
expressed by seeding efficiency of BMSCs. Hydrophilicity is an important parameter 
because it relates to the diffusion of nutrients and cellular waste. Moreover, it allows 
the maintenance of tissue fluid and nutrients which are necessary for cells to attach and 
proliferate. The result in Paper II is consistent with previous findings that modifying 
hydrophilicity by blending with surfactant significantly improved initial cell 
attachment onto biodegradable copolymer nanofibrous surfaces [207]. Moreover, the  
results of Paper III are in accordance with another study exhibiting enhanced cell 
adhesion when human osteoblast-like cells were seeded onto copolymer nanofibrous 
membranes functionalized with nDPs [208]. Copolymer scaffolds modified with nDPs 
may provide good support for the adhesion and growth of osteoblasts [149]. Increasing 
the amount of nDPs in gelatin fibrous scaffolds resulted in an upturn in the number of 
adherent cells [209]. A suitable surface can be provided by coating the polymer with 
nDPs, which in turn is beneficial for cell adhesion and growth via providing multiple 
binding sites for adhesion molecules [149, 210]. 
Although seeding efficiency has been associated primarily with the surface area 
available for cell attachment, numerous studies have shown that other factors such as 
surface chemistry, scaffold architecture, and the pore structure are also important [166, 
211]. Thus, the differences in cell seeding efficiency between pristine and modified 
scaffolds might be attributable to the synergistic effects of multiple contributing 
factors, such as increased hydrophilicity of the surfaces (Tween 80 and nDPs) and the 
influence of reactive functional groups (nDPs) on protein attachment/conformation. 
This is in agreement with the findings of a previous study showing that surface 
chemistry has a profound effect on cell adhesion, area of spread, and proliferation [212]. 
The synergistic effects of multiple causal factors, such as surface wettability and 
surface functional groups, may influence all cellular events [212]. The generated data 
clearly confirm that modification of surface hydrophilicity has a bearing on the 
seeding efficiency. 
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11.2.2 Modifying poly(LLA-co-CL) with 3% Tween 80 enhanced ectopic bone 
formation 
Tween 80 is a hydrophilic nonionic surfactant commonly used in drug delivery 
systems and for dispersion of substances in medical and food products [213-215]. One 
advantage of using Tween 80 as a hydrophilic additive in fabricating 3D porous 
scaffolding is that it does not readily leach out into water or cell culture medium, 
owing to the hydrophobic interaction between the hydrophobic long alkyl tail of 
Tween 80 and the polymer main chain [129]. Blending Tween80 with a hydrophobic 
scaffold polymer has previously been described, producing hydrophilic polymers [128, 
129]. However, inconsistent in vitro cell culture results indicated that the concentration 
of Tween 80 needs to be optimized before proceeding to in vivo experiments. 
In Paper II, blending 3% (w/w) Tween 80 with poly(LLA-co-CL) improved 
the hydrophilicity and after 2 weeks of subcutaneous implantation, significantly 
upregulated expression of Runx2 was observed. At 8 weeks, there was a significant 
increase in de novo bone formation (Figure 15).  
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Figure 15. μ-CT of implanted copolymer scaffolds loaded with BMSCs: (A) The 
histogram shows the statistical difference in bone/tissue formation between pristine 
poly(LLA-co-CL) and poly(LLA-co-CL)/3% Tween 80 modified scaffolds and (B) 
corresponding μ-CT images of the scaffolds. (* P ≤ 0.05)   
 Runx2 is recognized as a critical regulator of osteogenic development and 
induces the expression of osteogenic extracellular matrix genes during osteoblast 
maturation e.g. osteocalcin [216, 217]. Culturing osteoblasts on hydrophilic surfaces 
might lead to increased expression of osteogenic markers [218]. In skeletal development, 
bone formation from condensing mesenchymal cells involves two distinct pathways: 
endochondral and intramembraneous ossification [219]. Both processes are dependent 
on optimal carrier properties and cell seeding density [220]. For example, depending 
upon the surface properties of the polymer scaffolds, stem cells differentiate towards 
an osteogenic phenotype and in vivo produce bone tissues through two different 
pathways [221]. In hydrophilic polymer scaffolds [222] ectopic bone formation associated 
with subcutaneous transplantation of human embryonic stem cells, demonstrated that 
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modifying the polymeric scaffolds with hydroxyapatite upregulated Runx2 and 
resulted in bone formation through an intramembranous ossification pathway [221]. This 
can explain the results of Paper II, whereby a large quantity of collagenous and 
mineralized matrix was deposited on hydrophilic copolymer scaffolds. Moreover, it 
may be assumed that a hydrophilic surface is advantageous for tissue regeneration and 
the cascade of events that occurs during osseointegration [223]. Thus, the results of the 
present series of studies further contribute to the body of evidence that the osteogenic 
potential of BMSCs is highly dependent on the physical and chemical architecture and 
surface properties of polymeric scaffolds.  
11.2.3 nDPs enhanced the osteoconductive properties of poly(LLA-co-CL) 
scaffolds  
Paper III documented that functionalizing poly(LLA-co-CL) scaffolds with nDPs 
altered the surface topography. Moreover, in the calvarial defects, poly(LLA-co-
CL)/nDPs scaffolds exhibited enhanced osteogenic metabolic activity and showed 
significantly increased bone formation. Cellular sensing of extracellular 
nanotopographical cues initiates downstream intracellular mechanotransductive 
events, resulting in a multitude of nanotopography-sensitive cellular behaviors, 
including cell adhesion, proliferation, self-renewal, and differentiation [224-226]. 
Enhanced osteogenic differentiation, measured as upregulated expression of 
osteogenic markers, was observed when mesenchymal stem cells derived from human 
bone marrow were seeded onto nanostructured titanium surfaces [227]. In another study, 
miRNA analysis confirmed that exposure of stem cells to nanoparticles affects the 
genes responsible for osteogenic differentiation [228]. It has also been shown that 
functionalization of polymer scaffolds with nDP not only supports the proliferation, 
but also controls the osteogenic differentiation of BMSCs in vitro [149]. Thus, the 
introduction of nanoscale structures may improve osteoblast differentiation, indicating 
a potential to improve osseointegration of the engineered construct.  
As shown in Paper III, the uptake of [18]F-NaF is directly proportional to the 
metabolic activity of living osteogenic cells [229]. The data obtained from 
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multimodality PET/CT systems (Figure 16) suggest an increase in the osteogenic 
metabolic activities of BMSCs when seeded into poly(LLA-co-CL)/nDPs scaffolds.  
 
Figure 16. PET/CT analysis (A) Images for each animal of experimental groups (pristine 
poly(LLA-co-CL) or functionalized with nDPs seeded with BMSCs) after 4 (left side) and 12 
(right side) weeks. (B) SUVmean and SUVmax values extrapolated from the quantitative 
analysis of images acquired at 4 and 12 weeks. 
Acid treatment of nDPs following oxidative purification selectively increases 
the number of oxygenated functional groups. These groups may lead to modulation of 
the adsorbed protein i.e. fibronectin (FN) [230], resulting in recruitment of different 
levels of focal adhesion components, and therefore cell attachment, proliferation, and 
osteogenic differentiation [231-233]. Further, the surface nanotopography can enhance 
osteogenic differentiation of stem cells synergistically with a biochemical induction 
substance [234]. In the in vivo experiment in Paper III, at twelve weeks, implantation of 
poly(LLA-co-CL)/nDPs seeded with BMSCs resulted in significant bony bridging of 
the defect. The increased bone volume within the defect was shown by μ-CT and 
confirmed histologically. In combination, these data suggest that the local 
microenvironment, generated by interactions among modified polymer scaffolds, 
 
UiB | 11. Main Results and Discussion 59 
 
BMSCs, and native cells may regulate the osteogenic activity induced by the 
biomaterials and/or stem cells [149]. The osteoconductivity of poly(LLA-co-CL)/nDPs 
is attributed to surface hydrophilicity as well as to surface charge, which allows 
osteoblastic differentiation of the seeded cells [235]. Moreover, under in vivo conditions 
copolymer scaffolds functionalized with nDPs might modulate protein adsorption to 
recruit host osteoprogenitor cells [149]. Thus poly(LLA-co-CL)/nDPs scaffolding may 
facilitate bone formation, either alone [149], in combination with growth factors [148],  or 
stem cells (Paper III). 
11.2.4 Reduction of albumin adsorption in hydrophilic copolymer scaffolds  
In cell–material interactions, protein adsorption is the first event to occur at the 
solid/liquid interface when materials are exposed to culture media or body fluid.  
Cellular attachment, proliferation, and migration then follow [236]. Protein adsorption 
occurs on the scaffold surface, mediating cell adhesion, and also provides signals to 
the cell through the cell adhesion receptors, mainly integrin [237]. Thus, protein 
adsorption plays a vital role in bone tissue regeneration [238]. The effect of different 
materials and surface properties on the amounts and types of bound proteins, as well as 
the conformation, orientation or binding strength of the adsorbed protein, is well 
documented [239, 240]. The influence of surface hydrophilicity on albumin adsorption 
was assessed as illustrated in Figure 17.  
Serum albumin is the main protein of human blood plasma and represents 
around 50–60% of the total plasma protein fraction [241]. Its most important 
physiological functions are to maintain the osmotic pressure and pH of blood and to 
transport a wide variety of endogenous and exogenous compounds, including fatty 
acids, metals, amino acids, steroids, and drugs [241]. In the present series of studies, 
bovine serum albumin (BSA) was chosen as an experimental protein because of such 
favorable properties as solubility in water, stability, and availability at high purity [242]. 
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Figure 17. BSA adsorption rate measurements. BSA overall adsorption rate as a function 
of surface hydrophilicity. (* P ≤ 0.05) 
Compared with the pristine scaffolds, there was a significant reduction in 
adsorbed albumin on the scaffolds modified with nDPs. Commonly used polymers are 
mostly hydrophobic and have high affinity to a wide variety of proteins [239, 243]. The 
proteins tend to adsorb onto the hydrophobic surface by hydrophobic patches of 
residues present in the protein’s amphiphilic structure [240]. The proteins are adsorbed 
via hydrophobic interactions and tend to assume an altered conformation and to expose 
hydrophobic domains which become tightly adherent to hydrophobic biomaterial 
surfaces [244]. Hydrophobic surfaces tend to adsorb more protein than hydrophilic 
surfaces because a stronger attraction to the protein will result in a denser layer of 
protein on the surface [245]. Thus modifying the surface hydrophilicity of poly(LLA-co-
CL) through blending with Tween 80 [128] or functionalizing with nDPs [149, 246] might 
result in selective adsorption of proteins due to the hydrated interfacial phase between 
hydrophilic surfaces and proteins [121]. A previous study has shown suppressed 
albumin adsorption in hydrophilic polymer scaffolds [163]. In another study, modifying 
poly(D,L-lactide-co-glycolide) with poly(ethylene oxide) led to transformation of 
hydrophobic degradable polyesters to hydrophilic fibers, which caused suppression of 
albumin adsorption on the surface of the fibers [247]. A study focusing on the influence 
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of nanotopography on protein conformation and adsorption has shown a significant 
reduction in protein adsorption on the curved nanoscale surface compared with the flat 
surface [248]. It has been speculated that nano-roughness is significantly smaller than 
the dimensions of albumin ( 10 nm) and this might reduce albumin adsorption [249]. 
The reduction of albumin adsorption to polymer surfaces is believed to be a vital step 
for the generation of specific cell adhesion and for triggering the immune system by 
reducing of fibrous capsule thickness and inhibiting macrophage adhesion to the 
implant in vivo [163]. Therefore, both composition and conformation of an adsorbed 
protein layer are considered to be critical factors in determining the nature of the cell-
scaffolds interaction [117]. 
11.2.5 Impact of hydrophilicity on biocompatibility and efficacy of poly(LLA-co-
CL) 
Water is an important determinant of biocompatibility and efficacy of synthetic 
materials. It has been assumed that high water levels within the surface of materials 
might help to provide low interfacial free energy with blood and reduce protein 
adsorption to the polymeric surface  [239]. “The biocompatibility of a scaffold or matrix 
for a tissue engineering product refers to the ability to perform as a substrate that will 
support the appropriate cellular activity, including the facilitation of molecular and 
mechanical signaling systems, in order to optimize tissue regeneration, without 
eliciting any undesirable local or systemic responses in the eventual host” [20]. In 
accordance with this definition, the results of Paper II and Paper III show that 
surface modification of the hydrophilicity of poly(LLA-co-CL) scaffolding improved 
its cyto-histocompatibility i.e. the improved wettability actively promoted the 
proliferation and differentiation of BMSCs in vitro and in vivo.  
It is generally accepted that a protein-resistant surface (e.g. hydrophilic in 
nature and the presence of hydrogen bond acceptors) can help to tailor material 
surfaces to control protein adhesion and interactions following adsorption, and may 
thus improve biocompatibility [239]. In evaluating biocompatibility, assays of cellular 
events (e.g. proliferation and differentiation) are important. In Paper II, hydrophilic 
scaffolds exhibited significant increases in cell proliferation. Moreover, the findings in 
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Paper III indicated improved osteogenic metabolic activity in the calvarial defects 
treated with modified scaffolds. Overall, this suggests that the modified scaffold 
provides better conditions for efficient transport of cell culture medium into the 
scaffold and therefore improved oxygen and nutrient transport to the seeded cells and 
the host cells [49]. Further, it has been reported that a hydrophilic polymer surface 
triggers the immune system by inhibiting adhesion of inflammatory cells [247, 250]. 
Several studies have reported that surface functionality/hydrophilicity may alter 
biomaterial-mediated acute inflammatory responses and minimally influence chronic 
fibrotic responses in vivo [251, 252]. Further investigations into inflammatory responses 
could provide more information about the biocompatibility and efficacy of the 
modified scaffolds.  
The results of this series of studies confirm that under both in vitro and in vivo 
conditions, hydrophilic modification of poly(LLA-co-CL) influences protein 
adsorption and induces positive cellular responses, including proliferation and 
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12. Conclusions  
 
 
The following conclusions can be drawn from the included studies: 
 
 
 The appropriate number of cells to be loaded onto a specific scaffold is a 
critical factor in promoting ECM synthesis and bone formation.   
 The maturation stage of mesenchymal stem cells is a key factor in inducing new 
bone tissue formation. 
 Modifying scaffold surfaces by increasing hydrophilicity improves the seeding 
efficiency of BMSCs and suppresses albumin adsorption.  
 Modification of porous degradable scaffolds with 3% Tween 80 increases 
BMSCs proliferation, promotes osteogenic differentiation of BMSCs and de 
novo bone formation. 
 nDPs influence the surface properties of copolymer scaffolds resulting in 
enhanced osteoconductive potential and promoting bone regeneration.  
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13. Future Perspectives  
“The best thing about the future….is that it comes one day at a time”  
Abraham Lincoln  
 
In field of tissue engineering, polymeric materials show great promise as scaffolds 
materials. The parameters of biomimetic scaffolds, including mechanical properties, 
bioactive agent release profile, architecture, and interactions with cells, are all highly 
dependent on fabrication technologies. The next generation scaffolding technique 
(3DF) may customize bio-inspired artificial extracellular matrices, incorporating 
optimal physical and chemical surface properties to improve stem cell support. Stem 
cells delivered by designed scaffolds can then guide and stimulate reconstruction of 
functional tissues in vivo. Furthermore, rapid advances in stem cell biology have led to 
increased availability of a variety of cell types which may also be employed with 
spatial control, e.g. in the form of printed 3D cells/organs, to generate complex tissues 
ex vivo, with tissue hierarchy. 
With reference to Tween 80 and nDPs modifications, further studies are needed 
to understand the immunogenic responses, because implantation of a biomaterial 
always initiates an inflammatory foreign body reaction. Moreover, there is a need for 
models focusing on treatment of long bone defects, in order to establish the 
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Abstract: Constructs intended for bone tissue engineering (TE)
are influenced by the initial cell seeding density. Therefore, the
objective of this study was to determine the effect of bone mar-
row stromal stem cells (BMSCs) density loaded onto copolymer
scaffolds on bone regeneration. BMSCs were harvested from
rat’s bone marrow and cultured in media with or without osteo-
genic supplements. Cells were seeded onto poly(L-lactide-co-e-
caprolactone) [poly(LLA-co-CL)] scaffolds at two different den-
sities: low density (1 3 106 cells/scaffold) or high density (2 3
106 cells/scaffold) using spinner modified flasks and examined
after 1 and 3 weeks. Initial attachment and spread of BMSC onto
the scaffolds was recorded by scanning electron microscopy.
Cell proliferation was assessed by DNA quantification and cell
differentiation by quantitative real-time reverse transcriptase-
polymerized chain reaction analysis (qRT-PCR). Five-millimeter
rat calvarial defects (24 defects in 12 rats) were implanted with
scaffolds seeded with either low or high density expanded with
or without osteogenic supplements. Osteogenic supplements
significantly increased cell proliferation (p < 0.001). Scaffolds
seeded at high cell density exhibited higher mRNA expressions
of Runx2 p5 0.001, Col1 p5 0.001, BMP2 p<0.001, BSP
p<0.001, and OC p5 0.013. More bone was formed in response
to high cell seeding density (p5 0.023) and high seeding density
with osteogenic medium (p5 0.038). Poly (LLA-co-CL) scaffolds
could be appropriate candidates for bone TE. The optimal num-
ber of cells to be loaded onto scaffolds is critical for promoting
Extracellular matrix synthesis and bone formation. Cell seeding
density and osteogenic supplements may have a synergistic
effect on the induction of new bone.VC 2015 Wiley Periodicals, Inc. J
BiomedMater Res Part A: 103A: 3649–3658, 2015.
Key Words: bone marrow stromal cells, polymer scaffolds,
cell seeding density, osteogenic supplements, bone
regeneration
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INTRODUCTION
Aliphatic polyesters such as poly(lactide), poly(lactide-co-
glycolide), and poly(e-caprolactone) and their synthesized
copolymers are the most common synthetic biodegradable
polymers used as scaffolding in bone tissue engineering
(TE). By copolymerization of e-caprolactone with different
lactones, the physical and mechanical properties of the poly-
esters can be tailored, extending the range of applications of
scaffolds.1 Poly(L-lactide-co-e-caprolactone) [poly(LLA-co-
CL)] possesses appropriate mechanical and physical proper-
ties. Not only the degradation rate but also the shape of the
scaffolds can readily be modified.2–4 Moreover, animal stud-
ies have confirmed that endothelial microvascular networks
can be created in porous scaffolds of 3D copolymer and sus-
tained after implantation.5
In developing TE constructs which may influence the
features and functionality of the engineered tissues, cell
seeding density is a critical factor. The optimal seeding den-
sity of a scaffold depends on the scaffold biomaterial, the
structure of the scaffold, and the seeding technique.6,7 The
influence of cell seeding density on TE constructs has been
studied in cardiac tissue, cartilage, and bone.8–10 In bone
TE, cell seeding density influences cell proliferation, distri-
bution, differentiation, extracellular matrix (ECM) synthesis,
and tissue formation.11–16 It has been reported that bone
marrow stromal cells (BMSCs), cultured at density of 6.83
3 105 cells/cm2 in three-dimensional (3D) poly(DL-lactic-co-
glycolic acid) scaffolds, exhibited rapid proliferation over
the first 7 days.17 Increasing the number of BMSCs from
3.54 3 104 to 3.54 3 105 cells/cm2 promoted osteogenic
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expression in titanium mesh.18 Similarly, Zhou et al.
demonstrated that the total number of cells loaded onto
polycaprolactone\tricalciumphosphate scaffolds significantly
influenced the production of ALP and osteocalcin.19 In rab-
bit segmental bone defect it was shown that a density of
1.5 3 106 cells/scaffold stimulated bone deposition after 2
weeks.20 However, another study reported that an increase
in cell seeding density from 1 to 6 3 106 cells/mL did not
enhance bone formation, but promoted more homogenous
cell distribution throughout the constructs.21 Further, in vivo
studies on cartilage and bone formation have failed to dem-
onstrate any significant effects of high cell seeding density
in 3D porous scaffolds.9,22 The inconclusive results indicate
the need for further evaluation of the in vitro and in vivo
effects of cell seeding density.
BMSCs have been widely used and investigated because
they can be expanded in vitro and differentiated into a vari-
ety of cell types such as adipocytes, chondrocytes, myoblasts,
and osteoblasts, by supplementing the cell culture medium
with specific growth and differentiation factors.23–25 Osteo-
genic differentiation of BMSCs can be induced by the
introduction of supplements such as ascorbic acid, dexameth-
asone, and b-glycerophosphate into the culture medium.26,27
It has been reported that preculture of BMSCs in osteogenic
medium for a short period may promote osteogenesis.28 On
the other hand, a published study demonstrated that osteoge-
netic activity is significantly higher in non-preculture of
BMSCs.29 These contradictory findings indicate that the
in vivo effect of osteogenic medium needs to be further
addressed.
The main objective of this study was to assess the osteo-
genic potential of a tissue-engineered construct of BMSCs
and poly(LLA-co-CL) scaffolds in vitro and in vivo, using the
critical size defect model. A further objective was to deter-
mine the effect of low and high seeding density of BMSCs,
cultured with and without osteogenic supplements, on cell
proliferation and differentiation and on bone formation. The
synergistic effect of seeding density and osteogenic supple-
ments was also studied.
MATERIALS AND METHODS
Preparation of polymer scaffolds
Copolymer poly(LLA-co-CL) material was synthesized as
previously described.30 In brief, monomer, initiator, and cat-
alysts were weighed inside a glove box and bulk polymer-
ized at 1108C for 72 h, then precipitated three times in cold
hexane and methanol. Porous scaffolds were produced from
the copolymer using a solvent-casting-particulate-leaching
method. The pore size was >90 lm and the porosity 90%.
After leaching of salt particles, the scaffolds were dried and
sterilized in an inert atmosphere using electron beam radia-
tion at a dose of 2.5 Mrad from a pulsed electron accelera-
tor (Mikrotron, Acceleratorteknik, Stockholm, Sweden) at
6.5 MeV.
Cell isolation
Bone marrow stromal cells (BMSCs) were isolated from the
femurs of two donor Lewis rats and maintained by a modifi-
cation of a method previously described.31 The animals
were housed under uniform conditions for at least 1 week
before the experiment, then euthanized by an overdose of
carbon dioxide (CO2) inhalation. The femurs were retrieved,
cleaned, and washed three times for 5 min in phosphate-
buffered saline (PBS) supplemented with 3% penicillin–
streptomycin (PS). The metaphyseal ends of the femurs
were cut off, and the marrow cavity was flushed with mini-
mum essential medium (aMEM, InvitrogenTM, Carlsbad, CA)
supplemented with 1% PS and 15% fetal bovine serum
(FBS) into a sterile falcon tube. The cells were centrifuged
and resuspended in fresh a-MEM medium containing 15%
FBS and plated in culture flasks (NUNC A/S, Roskilde, Den-
mark). The medium was changed the next day, with fresh
aMEM medium containing 1% PS and 10% FBS. Cells were
cultured in aMEM 1% AB and 10% FBS until they reached
80% confluence, after which they were passaged. Passages
3–5 were used for the in vitro studies and passages 3 and 4
for the in vivo studies. Half of the cells were cultured in
aMEM only, supplemented with 1% PS and 10% FBS. For
the other half, the culture medium was supplemented with
osteogenic factors [100 nM dexamethasone (dex), 10 mMb
glycerophosphate, and 0.05 mM ascorbic acid]11,32 7 days
before the experiments.
The study was approved by the Norwegian Animal
Research Authority and conducted according to the Euro-
pean Convention for the Protection of Vertebrates Used for
Scientific Purposes (local approval number 20124903).
Scanning electron microscopy
The poly(LLA-co-CL) scaffolds with BMSCs seeded at differ-
ent densities were examined under scanning electron
microscopy (SEM) to determine cell adhesion and spreading.
After 7 and 21 days of culture, samples were prepared for
SEM as follows; first, the medium was replaced with 2.5%
glutaraldehyde in a-MEM without serum and fixed for 30
min at room temperature. Second, samples were fixed in
2.5% glutaraldehyde in 0.1M sodium cacodylate pH 7.2 with
0.1M sucrose for 30 min at room temperature. The samples
were then treated with 1% osmium tetroxide in distilled
water for 1 h, followed by dehydration through a graded
series of ethanol solutions (70, 80, 95, and 100%), critical-
point-dried (using CO2 as transitional fluid and the speci-
mens mounted on aluminum holders), and sputter-coated
with a 10 nm conducting layer of gold platinum. Finally, the
samples were examined by SEM (Jeol JSM 7400F, Tokyo,
Japan) using a voltage of 10 kV.
DNA quantification of cell proliferation
DNA quantification was carried out as described previously,
with some modifications,33 using reagents from the Master-
PureTM Complete DNA and RNA Purification Kit (EpicentreV
R
Biotechnologies, Madison, WI). The amount and purity of
DNA per scaffold (n5 4 scaffolds for each group and time
point) were measured by optical densitometry at 260 and
280 nm, using a Nanodrop ND 1000 spectrophotometer
(NanoDrop Technologies, Wilmington, DE).
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Real-time reverse transcription-polymerase chain
reaction analysis
RNA isolation and RT-PCR were performed as described pre-
viously.32 Briefly, total RNA was collected from cells grown
onto the scaffolds (n54 scaffolds for each group and time
point) using an isolation kit (E.Z.N.AVR, Omega Bio-Tek, Nor-
cross, GA) according to the manufacturer’s protocol. RNA
purity and quantification were determined by spectropho-
tometry (NanoDrop Spectrophotometer, NanoDrop Technolo-
gies). Real-time reverse transcription-polymerase (RT-PCR)
was conducted under standard enzyme and cycling condi-
tions on a StepOneTM real-time PCR system, using TaqManVR
gene expression assays (Applied BiosystemsTM, Carlsbad,
CA): runt-related transcription factor 2 (Runx2), collagen
type I (Col I), alkaline phosphatase (ALP), bone morphoge-
netic protein 2 (BMP2), bone sialoprotein (BSP), osteocalcin
(OC), and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH). The data were analyzed using a comparative Ct
method by StepOne. Expression levels of the genes were
normalized to the Housekeeper index with GAPDH serving
as the endogenous control.
Graft preparation
Poly (LLA-co-CL) scaffolds were placed at the bottom of
wells in 96-well plates, prewet with the culture media, and
incubated at 378C and 5% CO2 overnight. The following
morning, BMSCs were trypsinized from the culture flasks
and seeded on the top of each scaffold, at low density (1 3
106 cells/scaffold) or high density (2 3 106 cells/scaffold).
An orbital shaker (EppendorfVR, Hamburg, Germany) was
applied to facilitate the distribution of the cells from the
surface of the scaffold into the pores.6 The cell/scaffold
grafts were incubated for 3 h for cell attachment and then
transferred either to rat calvarial bone defects (n5 12 rats)
for 8 weeks or to four separate spinner flasks (Wheaton Sci-
ence, Millville, NJ).32 The spinner flasks were placed on a
magnetic stirrer (Stem Stirrer, UK) and the side arm caps
kept loose. The grafts were separated by spacers made of
silicone tubes and cultured in a CO2 incubator for 3 weeks.
Surgical procedure and implantation
Twelve male Lewis rats (2.5 months old, weight: 300–
350 g) were kept in the animal facility for 1 week to accli-
matize to diet, water, and housing, under a 12 h/12 h light/
dark cycle. The rats were anesthetized with isofluorane
(Isoba vetVR, Schering Plough, Kenilworth, NJ) in combina-
tion with NO2 and O2, using a custom-made mask. The sur-
gical site was shaved and scrubbed with 70% alcohol. Using
sterile instruments and an aseptic technique, a 2-cm antero-
posterior cranial skin incision was made along the midline.
The subcutaneous tissue, musculature, and periosteum were
dissected and reflected to expose the calvaria. A full-
thickness defect (5 mm in diameter) was created in the cen-
tral area of each parietal bone, using a saline-cooled tre-
phine drill to prevent overheating of the bone margins and
to remove the bone debris. The dura mater was left undis-
turbed. Twenty-four defects were implanted with disc-
shaped scaffolds of poly(LLA-co-CL), 5 mm in diameter 3
1.5 mm height, seeded with high or low cell density using
two cell culture environment: in medium with or without
osteogenic supplements. Accordingly, the scaffolds were
classified into four different groups:
i. Six defects implanted with scaffolds seeded with cells in
low density without osteogenic supplements (LD-OM).
ii. Six defects implanted with scaffolds seeded with cells in
high density without osteogenic supplements (HD-OM).
iii. Six defects implanted with scaffolds seeded with cells in
low density with osteogenic supplements (LD1OM).
iv. Six defects implanted with scaffolds seeded with cells in
high density with osteogenic supplements (HD1OM).
The periosteum and skin were repositioned and stabi-
lized with sutures (Vicryl Plus 4-0). Topical antibiotic Baci-
mycine (Bacitracin ointment) was applied to the wound to
prevent postoperative infection. All animals were given an
intramuscular dose of Buprenorphine (TemgesicV
R
0.3 mg\kg)
as an analgesic and allowed to recover. The status of the
surgical wound, food intake, activity, and signs of infection
were monitored daily. After 8 weeks, the animals were
sacrificed by inhalation of CO2 and the calvarial defects with
surrounding bone and soft tissue were harvested for
subsequent evaluation.
X-ray micro-computed tomography
For quantitative evaluation of new bone formation in the rat
calvarial defects at 8 weeks, micro-computed tomography
(lCT) scans were taken using the SkyScan1172VR microfo-
cus X-ray system (SkyScanVR, Kontich, Belgium) with the
CTAn 1.8VR and NRECON RECONSTRUCTIONVR CT software
(SkyScanVR), as previously described.34 A 0.5-mm aluminum
filter was used to optimize the images. Source voltage and
current were set at 50 kV and 200 lA, respectively. After
operating CTAn 1.8VR to each reconstructed BMP files, bone
volume (BV), tissue volume (TV), and bone volume/tissue
volume (BV/TV) values were obtained.
Histology
Specimens for histological examination were fixed with 4%
paraformaldehyde (Merck, White House Station, NJ) and
decalcified for 4 weeks, using 10% ethylenediaminetetraace-
tic acid (EDTA) in 0.1M Tris buffer and 7.5% polyvinylpyr-
rolidone (PVP) (Merck). The specimens were then washed
in PBS, embedded in paraffin, and serially sectioned using a
microtome (HM 325, Thermo Scientific). The sections, 4–6
lm thick, were mounted on glass slides, deparaffinized,
hydrated by the application of xylene and alcohol in series,
and stained with Masson’s Trichrome (MT).
Statistical analysis
Sixteen scaffolds were available for the statistical analyses.
From each scaffold four measures were taken: two at day 7
and 2 at day 21. Twelve rats were included in the in vivo
analysis. To provide more accurate data of the hierarchical
structure of the outcome variables a multilevel modeling
analysis was applied. For the PCR statistical analyses,
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reference values were first calculated for the low seeding
densities without osteogenic medium, for day 7 and day 21,
respectively. This was done for all the expression measures.
A random effect model with each particular gene as the ran-
dom factor (to control for the two repeated measures for
each gene) was applied. The reference value was defined as
the predicted mean from these models. DCt values for each
gene were thereafter calculated as the difference between
the gene measures and the reference values. The DDCt val-
ues for all the expressions were then analyzed in linear
models using robust variance estimates to control for the
repeated measures for each particular gene. Mean values,
standard deviations, and 95% confidence intervals were
estimated from these models. For low seeding densities
without osteogenic medium the mean values are by defini-
tion “0.” For DNA and the lCT the measured values were
used directly in the analyses.
The effects were tested hierarchically. First the main
effects of seeding density, osteogenic medium, and days
were tested. Thereafter, a model including the first-order
interaction was performed (densities*medium, medium*-
days, density*days), and then a model including the second-
order interaction (densities*medium*days). The lCT obser-
vations were measured at only one time point. This analytic
approach will correspond to performing repeated measures
analyses of variance. The statistical package StataIC version
13 was used to analyze the data. The p-values less than
0.05 were considered statistically significant.
RESULTS
SEM analysis
Scaffolds with low and high cell seeding densities preincu-
bated in different media demonstrated good cellular attach-
ment at day 7 and day 21. The cells appeared to be
flattened and well spread, covering the surface of the scaf-
folds and migrating into the inner pores of the scaffolds
(Fig. 1).
Cell proliferation
Osteogenic medium and incubation time showed a signifi-
cant overall positive effect on the quantity of DNA
(p50.001), whereas cell seeding density showed no overall
effect (p5 0.32). There was a significant relationship
between osteogenic medium and incubation time
(p50.001). The pairwise comparison at day 7 showed a
significant stimulating effect of high cell seeding density
with osteogenic medium on the amount of DNA compared
with low cell seeding density with osteogenic medium
(p50.039). Similarly, high cell seeding density with osteo-
genic medium significantly stimulated the amount of DNA
compared with high cell seeding density without osteogenic
medium (p< 0.001). For the pairwise comparison at day 21,
significantly higher amounts of DNA were detected for high
cell seeding density with osteogenic medium than for high
cell seeding density without osteogenic medium (p<0.001)
(Fig. 2).
RT-PCR
Runx2 expression exhibited significant overall upregulation
in relation to high cell seeding density (p5 0.001) and sig-
nificant overall downregulation in relation to osteogenic
medium (p5 0.005). There were significant interactions
between high cell seeding density and incubation time
(p50.042) and between high cell seeding density and
osteogenic medium (p50.046). The pairwise comparison at
day 7 revealed a significantly higher expression of Runx2
for scaffolds with high cell seeding density with osteogenic
medium compared with low cell seeding density with osteo-
genic medium (p5 0.042). By day 21, Runx2 expression had
increased significantly for high cell seeding density without
FIGURE 1. SEM images of scaffolds 1 week (1W) (A–D) and 3 weeks (3W) (E–H) after seeding with cultured BMSCs. A and E: Low cell seeding
density with cells preincubated with osteogenic medium. B and F: High cell seeding density with cells preincubated with osteogenic medium.
C and G: Low cell seeding density with cells preincubated without osteogenic medium. D and H: High cell seeding density with cells preincubated
without osteogenic medium. Although seeded at different densities and preincubated with and without osteogenic medium, all cells appear to be
flattened and well spread on the scaffolds. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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osteogenic medium compared with low cell seeding density
without osteogenic medium (p5 0.032). Moreover, from day
7 to day 21, Runx2 expression was significantly upregulated
in scaffolds with high cell seeding density without osteo-
genic medium (p5 0.029) [Fig. 3(A)].
Col1 expression disclosed a significant overall upregula-
tion effect of high cell seeding density (p5 0.009). There
were also significant interactions between high cell density
and incubation time (p5 0.009) and osteogenic medium
and incubation time (p50.019). Pairwise comparison at
day 21 showed significantly higher expression of Col1 for
scaffolds with high cell seeding density without osteogenic
medium than for low cell seeding density without osteo-
genic medium (p5 0.011) [Fig. 3(B)].
ALP expression was not overall significantly affected by
high cell seeding density (p5 0.38) or osteogenic medium
(p50.69). Significant relationships were disclosed between
osteogenic medium and incubation time (p< 0.001) and
among high cell seeding density, osteogenic medium, and
incubation time (p5 0.026). The pairwise comparison at
day 7 showed significant upregulation of ALP associated
with high cell seeding density with osteogenic medium com-
pared with low cell seeding density with osteogenic medium
(p50.020). Similarly, high cell seeding density with osteo-
genic medium showed significant upregulation of ALP
FIGURE 3. mRNA expression of (A) Runx2, (B) Col 1, (C) ALP, (D) BMP2, (E) BSP, and (F) OC by qRT-PCR, presented as x-fold changes relative to
the expression of the mean of the calibrator sample LD-OM. A: Runx2 expression is downregulated by osteogenic medium (p5 0.005) and
upregulated by high cell seeding density (p50.001). B: Col1 expression is upregulated by high cell seeding density (p5 0.001). C: ALP expres-
sion, disclosing a significant relationship between high cell density, osteogenic medium, and number of days (p5 0.026). D: BMP2 expression is
upregulated by osteogenic medium (p< 0.001) and high cell seeding density (p5 0.003). E: BSP expression is upregulated by osteogenic
medium (p< 0.001) and high cell seeding density (p5 0.033). F: OC expression is upregulated by osteogenic medium (p50.002) and high cell
seeding density (p5 0.013). The data are presented as means695% confidence intervals.
FIGURE 2. Total DNA quantification of cultured cell/scaffold constructs
(n5 4 for each group and time point). The data are presented as
means695% confidence intervals. The results indicate continued pro-
liferation of BMSCs for up to 3 weeks (p50.001) and a positive effect
of osteogenic supplements on cell proliferation (p< 0.001).
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compared with high cell seeding density without osteogenic
medium (p5 0.05). By day 21, ALP levels from scaffolds
with high cell seeding density without osteogenic medium
showed significant upregulation compared with scaffolds
with high cell seeding density and osteogenic medium
(p50.021) [Fig. 3(C)].
BMP-2 expression was significantly overall upregulated
in scaffolds with high cell seeding density (p50.003) and
osteogenic medium (p< 0.001). Significant relationships
were disclosed between high cell seeding density and osteo-
genic medium (p5 0.047) and between osteogenic medium
and incubation time (p5 0.001). The pairwise comparison
at day 7 showed significant upregulation of BMP-2 in low
cell seeding density with osteogenic medium compared with
low cell seeding density without osteogenic medium
(p50.013). In addition, expression of BMP-2 in high cell
seeding density with osteogenic medium was significantly
upregulated compared with high cell seeding density with-
out osteogenic medium (p< 0.001) [Fig. 3(D)].
BSP expression showed significant overall upregulation
in scaffolds with high cell seeding density (p50.033) and
osteogenic medium (p< 0.001). In addition, the interaction
between osteogenic medium and incubation time was signif-
icant (p< 0.001). Pairwise comparison at day 7 and day 21
showed significant upregulation of BSP in low cell seeding
density with osteogenic medium compared with low cell
seeding density without osteogenic medium (p< 0.001) and
significant upregulation of BSP in high cell seeding density
with osteogenic medium compared with high cell seeding
density without osteogenic medium (p< 0.001) [Fig. 3(E)].
OC expression exhibited a significant overall upregula-
tion effect of high cell seeding density (p5 0.013) and
osteogenic medium (p5 0.002) [Fig. 3(F)].
lCT
Bone formation in the calvarial defects was evaluated at 8
weeks. In defects implanted with constructs seeded with
cells cultured at low density in nonosteogenic medium, heal-
ing was 14.27% (95% CI: 10.66, 17.88); the corresponding
rate for cells cultured at high density in nonosteogenic
medium was 14.46% (95% CI: 10.40, 18.51) (p5 0.99).
Healing of defects treated with cells preincubated in osteo-
genic medium was 13.43% (95% CI: 7.26, 19.61) for cells
cultured at low density and 21.71% (95% CI: 14.63, 28.79)
for those cultured at high density (p50.023). There was a
significant interaction effect between high cell density and
osteogenic medium (p5 0.038) (Fig. 4).
Histology
Various levels of osteoid-like tissue formation are illustrated
in Figure 5. Compared with the other groups, more bone-
like tissue formed in the group implanted with constructs
containing cells cultured in osteogenic medium at high cell
seeding density.
DISCUSSION
The objectives of this study were to determine the initial
biological responses, the osteogenic potential, and the
induction of new bone in response to implanted poly(LLA-
co-CL) scaffolds seeded with two different densities of
FIGURE 4. Bone formation in critical-size rat calvarial defects. A: Three-dimensionally reconstructed high-resolution lCT image of defects
implanted with cells/scaffolds after 8 weeks of healing. Note the new bone formed in the four groups; with osteogenic medium (1OM) or with-
out osteogenic medium (2OM) with different densities of cell seeding (low density (LD) or high density (HD)). B: Quantification of percentage of
area and volume of bone regeneration in calvarial defects after 8 weeks of healing. Implantation of scaffolds containing cells seeded at high
density and cultured with osteogenic medium exhibit a significant percentage of bone volume (p50.038). [Color figure can be viewed in the
online issue, which is available at wileyonlinelibrary.com.]
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BMSCs. The effects of cell seeding density and pretreatment
of BMSCs with osteogenic supplements on cell proliferation,
differentiation, and bone formation were also assessed.
Moreover, a potential synergistic effect of these factors was
evaluated.
In the in vitro experiments, the cells were cultured
under dynamic cell culture conditions, using spinner-
modified flasks. Previous studies show that the shear stress
induced by spinner flasks regulates cellular physiological
activity through stimulation of mechano-transduction path-
ways and promotes in vitro cell proliferation and differentia-
tion.33,35,36 Further, the critical size cranial defect model is
well established for evaluating orthotopic implantation.
However, calvarial bone has a relatively poor blood supply
and relative lack of bone marrow, that is, conditions less
than ideal for bone formation.37
Interactions of BMSCs with their microenvironment play
an important role in their morphogenesis and differentia-
tion. An important component of the cell microenvironment
is the surrounding matrix, which includes several biophysi-
cal and chemical signals. These signals are recognized, inte-
grated, and processed by the cells to determine the
behavior and function of the engineered tissues. It has been
shown that fibronectin, the extracellular protein present in
serum and plasma, is a major mediator of BMSC adhesion
to polymeric scaffolds.38 Thus, by controlling physical and
chemical characteristics of poly(LLA-co-CL) scaffolds, such
as solubility, degradation behavior, chemical composition,
crystallinity, and hydrophilicity, it is possible to regulate cell
survival, migration, proliferation, and differentiation during
the regeneration process.2,4,30,39
The number of cells capable of attaching to scaffolds
depends on the porosity, mean pore size, and surface area.
The porosity of poly(LLA-co-CL) scaffolds used in the cur-
rent experiments is about 85%, providing a large surface
area for cellular attachment and proliferation, conducive to
uniform cell distribution.40–42 In a previous study, co-
culturing BMSCs with endothelial cells at a density of 5 3
105 cells/scaffold resulted in low bone induction.32 Hence,
the number of cells was increased in this work. We
hypothesized that a large scaffold surface area containing
more attached cells would further stimulate bone formation.
Cell signaling can result either from direct cell2cell
communication or from secreted signaling molecules. With
high cell density, cell–cell communication and paracrine sig-
naling increase. Direct cell–cell communication via gap junc-
tions [i.e., gap junction intercellular communication (GJIC)]
is an important element promoting growth and differentia-
tion in various tissues.43 GJIC is mediated by connexins. In
particular, connexin 43 (Cx43) plays an important role in
regulating signal transmission among different bone cells.
Increased cell proliferation has been observed as a result of
connexin 43 stimulation.44 In this study, the in vitro data
generated at day 7 showed that high density seeding of the
copolymer scaffolds led to increased cell proliferation. This
stimulation is probably caused by GJIC activity. At day 21,
however, there was no correlation between cell proliferation
and cell seeding density, suggesting that maturation level
had been reached. A logarithmic relationship has been dem-
onstrated before between cell density and bone formation.13
The optimal cell density above which bone in-growth did
not change was identified, that is, increasing the cell num-
bers above this level did not stimulate more bone forma-
tion. This indicates that the direct cell–cell communication
through optimal cell seeding density and soluble osteogenic
factors might act as synergistic modulators in promoting
bone formation.
In animal studies, mesenchymal stem cells (MSCs) have
been reported to induce osteogenesis and have been used
extensively for regeneration of bone defects.29,45,46 The opti-
mal protocol for expanding MSCs in medium containing
osteogenic supplements may depend on the tissues from
which the MSCs were isolated; cells of different origin may
have inherited different degrees of osteogenicity.29,47,48
Osteoprogenitor cells can differentiate in the presence or
absence of osteogenic supplements.49 At least two classes of
osteoblast progenitor cells could be defined: those differen-
tiating in the absence of osteogenic supplements and those
requiring the supplements to differentiate. In the absence,
few cells differentiate and these are only detectable after
cell numbers are increased.49 This hypothesis is supported
by the in vitro data of the present work which demonstrate
that after 21 days in the absence of osteogenic supplements,
an increase in cell density upregulates the expression of
FIGURE 5. Representative sections of Masson’s trichrome staining through calvarial defects at 8 weeks (310). A: Section of a defect implanted
with a scaffold containing cells cultured without osteogenic medium and seeded at low density, showing fibrous connective tissue and collagen.
B: Defect implanted with a scaffold containing cells cultured without osteogenic medium and seeded at high density, showing osteoid-like tissue
(green areas). C: Defect implanted with a scaffold containing cells cultured with osteogenic medium and seeded at low density, showing
osteoid-like tissue. D: Defect implanted with a scaffold containing cells cultured with osteogenic medium and seeded at high density, showing
formation of a bridge of bone-like tissue. Scale bar51000 lm. [Color figure can be viewed in the online issue, which is available at wileyonline-
library.com.]
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osteogenic markers Runx 2, COL1, and ALP. Accordingly, the
osteogenic differentiation of BMSCs might depend on the
cell density, culture condition, and time. However, when
MSCs are fully differentiated, their pluripotency and immu-
nosuppressibility may also decrease and this may impair
osteogenicity and bone formation.50
Osteogenic differentiation of BMSCs proceeds in three
stages: early or commitment to osteogenic differentiation,
matrix synthesis, and then the final stage, mineralization.51 In
the osteoblastic differentiation model, cells proliferate rapidly
from 7 to 14 days and then start to secrete ECM proteins
and produce early differentiation markers such as ALP, which
is produced from day 7.52 Thereafter, as the cells mature,
proliferation decreases over time. In in vitro data of this
study, continued proliferation of BMSCs indicates that the
cells were still at the early maturation stage when the experi-
ments were conducted. mRNA expression of ALP was first
upregulated at day 7 and then downregulated at day 21. ALP
expression is controlled by BMP2 through the Wnt/LRP5 sig-
naling cascade.53 BMP2 is known to participate in the regula-
tion of cell growth and differentiation, along with the
induction of osteogenic progenitor cells in bone defect sites
during the healing process. In the group with high cell seed-
ing density and osteogenic supplements, there was a general
decline of BMP2 expression at day 21, suggesting that the
BMSCs had entered a maturation stage of differentiation.
In this work, cells cultured at high density with osteo-
genic supplements demonstrated an increase and upregula-
tion of osteocalcin mRNA expression during the experimental
period. Osteocalcin is a late, specific marker of osteoblast
maturation.54 This is in agreement with a previous report
showing that an increase in cell numbers in the presence of
osteogenic supplements upregulated osteocalcin expression
and maturation of osteoblasts.12 A correlation may exist
between increased extracellular protein secretion and an
increased number of mature osteoblasts, leading to promo-
tion of bone formation. Our in vivo data confirmed his obser-
vation demonstrating more bone formation in response to an
increase in the number of expanded and differentiated cells.
Accordingly, the present results indicate that the number of
mature osteoblast determined the rate of bone formation.
The in vivo findings demonstrate synergistic stimulation
of cell seeding density and osteogenic supplements on bone
formation. Dex is a synthetic glucocorticoid reported to be an
essential requirement for osteoprogenitor cell differentiation
of MSCs in vitro. The mechanism of action of dex on BMSCs
can be through induced transcription of BSP by binding on a
glucocorticoid response element in the promoter region of
the BSP gene, which is associated with osteoblast differentia-
tion.55 This was verified in vitro by BSP mRNA expression.
BSP is an indicator of cellular maturation. On the other hand,
osteogenic differentiation of BMSCs was clearly influenced by
the initial seeding densities via cell–cell communication.
Thus, both factors may accelerate osteoblastic differentiation,
leading primarily to more mature osteoblasts and secondarily
to more bone formation.
Although the in vivo data clearly confirm new bone for-
mation, the lCT images and histology at 8 weeks did not
show complete healing and bone regeneration. In bone TE,
the transplanted scaffold should act as a temporary ECM
substitute, stimulating cell attachment, proliferation, and dif-
ferentiation, with subsequent bone in-growth until finally
being completely degraded and replaced by regenerated
bone. Scaffold degradation should be adjusted appropriately
to the rate of neobone formation,56 thus allowing the
mechanical load on the scaffold to be transferred gradually
to the regenerated tissue. Finally, when total tissue regener-
ation has been achieved, the scaffold should be completely
degraded.
A previous in vivo study using similar scaffolds showed
slow, gradual degradation of the poly(LLA-co-Cl) scaffolds
within 91 days of the experimental period.4 The delayed
degradation of the scaffolds might suggest a longer healing
process in this experimental model.
CONCLUSIONS
The induction of new bone in a critical size defect indicates
that poly(LLA-co-CL) scaffolds are appropriate candidates
for constructs in bone TE. Bone regeneration might depend
on cell–cell communication, which is an important element
promoting growth and differentiation in various tissues. The
appropriate number of cells to be loaded onto a specific
scaffold is a critical, vital factor for promoting ECM synthe-
sis and bone formation. This study demonstrates that
increasing cell numbers seeded onto poly(LLA-co-Cl) scaf-
folds promote BMSCs differentiation and bone formation.
Osteogenic supplements are key determinants of the ability
of MSCs to induce new bone tissue formation. Thus, the syn-
ergistic effect of cell density and osteogenic supplements
appears to be of major importance in bone formation.
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Abstract: Poly(L-lactide-co-E-caprolactone) (poly(LLA-co-CL))
has been blended with Tween 80 to tune the material proper-
ties and optimize cell–material interactions. Accordingly, the
aims of this study were fourfold: to evaluate the effect of low
concentrations of Tween 80 on the surface microstructure of
3D poly(LLA-co-CL) porous scaffolds: to determine the effect
of different concentrations of Tween 80 on proliferation of
bone marrow stromal cells (BMSCs) in vitro under dynamic
cell culture at 7 and 21 days; to assess the influence of
Tween 80 on the degradation rate of poly(LLA-co-CL) at 7
and 21 days; and in a subcutaneous rat model, to evaluate
the effect on bone formation of porous scaffolds modified
with 3% Tween 80 at 2 and 8 weeks. Blending 3% (w/w)
Tween 80 with poly(LLA-co-CL) improves the surface wett-
ability (p<0.001). Poly(LLA-co-CL)/3% Tween 80 shows signif-
icantly increased cellular proliferation at days 7 and 21
(p<0.001). Moreover, the presence of Tween 80 facilitates
the degradation of poly(LLA-co-CL). Two weeks post-implan-
tation, the poly(LLA-co-CL)/3% Tween 80 scaffolds exhibit
significant mRNA expression of Runx2 (p5 0.004). After
8 weeks, poly(LLA-co-CL)/3% Tween 80 scaffolds show signif-
icantly increased de novo bone formation, demonstrated
by l-CT (p5 0.0133) and confirmed histologically. It can
be concluded that blending 3% (w/w) Tween 80 with poly
(LLA-co-CL) improves the hydrophilicity and osteogenic
potential of the scaffolds. VC 2016 Wiley Periodicals, Inc. J Biomed
Mater Res Part A: 104A: 2049–2059, 2016.
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bone formation, BMSCs
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INTRODUCTION
Porous scaffolding is used in tissue engineering (TE) as a tempo-
rary substitute for extracellular matrix (ECM): to promote cell
attachment, proliferation, and differentiation in the regeneration
of damaged or injured tissues or organs.1,2 A critical challenge is
to optimize scaffold material and design. Both natural and syn-
thetic polymer materials have been used as scaffolds.3,4 The
major advantage of synthetic polymers is that their chemical and
physical properties can be modified to provide an optimum scaf-
fold.5,6 Synthetic aliphatic polyesters such as poly (L-lactide)
(PLLA), poly (E-caprolactone) (PCL), poly glycolide (PGA), and
their copolymers, have documented potential as scaffolding in
bone defects.4 PLLA is brittle with a low degradation rate and
good tensile strength, whereas PCL is flexible with a low degrada-
tion rate and high toughness.7 Poly(L-lactide-co-E-caprolactone)
(poly(LLA-co-CL) shows great potential as a scaffold biomaterial
for TE, with important inherent properties such as biodegradabil-
ity, biocompatibility, nontoxicity, and thermoplasticity.5,6,8,9 Given
the significant relationship between surface hydrophilicity and
increased cell growth and differentiation, the hydrophobic prop-
erties of synthetic degradable polymers were found to inhibit
cellular attachment and growth, by limiting absorption/diffusion
of cell culture medium into the scaffold.10–12 Other critical
issues are seeding a sufficient number of cells and achieving
homogenous distribution throughout the entire structure of the
scaffold.13 Hydrophilic scaffolds can provide an optimal microen-
vironment for cell behavior, vital to the formation of well-
organized engineered tissues.14–17 Several modifications have
been proposed to improve hydrophilicity of degradable polymer
scaffolds such as ethanol prewetting,18 blending two polymers or
adjusting the monomer ratio within the copolymer,14,19,20 alka-
line hydrolysis,21 and plasma treatment of polymeric scaffolds.22
A recent study has shown that blending copolymers with a sur-
factant is also an effective means of adjusting hydrophilicity.23
Tween 80 is a nonionic surfactant, widely used in pharmaceutical
formulations and generally regarded as nontoxic and nonirri-
tant.24 It has three short hydrophilic polyethylene glycol (PEG)
chains and a relatively long hydrophobic alkyl chain.
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Tween 80 is amphiphilic: the balance between the
hydrophilic and hydrophobic fractions can determine its
application. Modification of poly(LLA-co-CL) with Tween 80
produces a highly hydrophilic scaffold, with the potential for
increased differentiation of human osteoblast-like cells.23
However, high concentration of Tween 80 had a toxic effect
on the cells.23 In the present study, poly(LLA-co-CL) has
been blended with low concentrations of Tween 80 to tune
the material properties and optimize cell-material interac-
tions in vitro and in vivo. Thus, the aims were fourfold: to
evaluate the effect of low concentrations of Tween 80 on
the surface microstructure of 3D poly(LLA-co-CL) porous
scaffolds; to determine the effect of different concentrations
of Tween 80 on proliferation of bone marrow stromal cells
(BMSCs) under dynamic culture conditions; to assess the
influence of different concentrations of Tween 80 on the
degradation rate of poly(LLA-co-CL) porous scaffolds; and
in a subcutaneous rat model to evaluate the effect on bone
formation of porous scaffolds modified with 3% Tween 80.
EXPERIMENTAL
Figure 1 shows the study design.
Material
Poly(LLA-co-CL) was synthesized by ring-opening polymeriza-
tion at 1108C for 72 h.25 E-Caprolactone (CL, Sigma-Aldrich,
Germany) was dried with CaH2 overnight and purified by dis-
tillation under reduced pressure at 908C. L-LA (LLA, Boeh-
ringer Ingelheim, Germany) recrystallized three times and
dried under vacuum for 3 days before use. Ethylene glycol
(Sigma-Aldrich, Germany) was used as the initiator and
Sn(Oct)2 (Sigma-Aldrich, Germany) as the catalyst. The mono-
mer to catalyst molar ratio was set at 10,000:1 to ensure a
low amount of residual tin. The copolymer product was pre-
cipitated in cold hexane/methanol three times and dried
under vacuum for >3 days. Molecular weights were recorded
by size exclusion chromatography (SEC) on a Verotech PL-GPC
50 (Polymer Laboratories, Varian, USA) system, equipped
with a refractive index detector and two Polar-Gel-M organic
GPC columns (300 3 7.5 mm) from Varian. The system was
calibrated against narrow polystyrene standards (Part No.
PL2010-0301, range 162–371, 100 g/mol, Varian). The
chemical composition and conversion rates (99%) of the
polymerization were determined by proton nuclear magnetic
resonance (1H NMR) spectrometry (Bruker AC 400, Bruker,
Switzerland).
Scaffold preparation
Poly(LLA-co-CL) and poly(LLA-co-CL)/Tween80 (Polysorbate
80 HX2TM, NOF Corporation, Ultra-Pure grade, Japan) were
fabricated using different Tween 80 concentrations [up to
3% (w/w)] by a previously described salt-leaching method.8
Accurate Tween 80 composition was determined by 1H
NMR according to a previously published method.23 Briefly,
A 4% (w/v) polymer solution was prepared in chloroform
and poured into silanized glass molds containing an NaCl (a
controlled particle size between 90 and 500 lm) to polymer
ratio of 10:1 by weight. Tween 80 was added and mixed
FIGURE 1. Study design.
2050 YASSIN ET AL. HYDROPHILICITY OF POROUS DEGRADABLE COPOLYMER SCAFFOLDS
overnight with the dissolved polymer solution at ratios of
0.5, 1, and 3% (w/w) in chloroform. After removing the
solvent, scaffolds were leached out with deionized water for
5 days, covered with aluminum foil and then dried under
vacuum. Copolymer without Tween 80 served as a control.
The scaffolds were then punched into cylinder shape of
5 mm diameter (Ø) 3 1.2 mm thickness (d) for in vitro and
in vivo application. The scaffolds were sterilized by electron
beam radiation (25 kGy dose) using a pulsed electron accel-
erator (Mikrotron, Acceleratorteknik, Stockholm) in an inert
environment at 6.5 MeV.
Characterization of the scaffold
The surface topography of unmodified poly(LLA-co-CL) scaf-
folds and poly(LLA-co-CL) scaffolds modified with Tween 80
was evaluated by scanning electron microscopy (SEM) using
Jeol JSM 7400F (Tokyo, Japan). All samples were dried and
sputter-coated with gold before analysis at an accelerating
voltage of 10 kV and magnifications up to 40,0003.
Microcomputed tomography (l-CT) was used to measure
the three-dimensional (3D) porosity, porous interconnectivity
and fractal dimension of the scaffolds. Three 5 mm 3 1.2 mm
cylindrical samples from each scaffold type were scanned
with a SkyScan 1172 l-CT imaging system (SkyScanVR
v.1.5.23, Kontich, Belgium) at 10 lm resolution using a voltage
of 40 kV, and a current of 250 mA. No filters were used in the
l-CT scanning of the scaffolds. Image reconstruction (NRecon
ReconstructionVR v. 1.6.10) and analysis (CTAn 1.15VR) were
conducted using the software package provided by SkyScan.
The raw images of scaffolds were first reconstructed to serial
coronal-oriented tomograms, using a 3D cone beam recon-
struction algorithm. A global thresholding procedure was
then performed at a threshold level of 40/255.
CAM 200 contact angle goniometry (KSV Instruments,
Finland) was used to measure the contact angles of a 5 lL
Milli-Q water drop on the surface of homogenous films,
prepared by dissolving porous scaffolds in chloroform. The
samples were prepared by spin coating corresponding
polymer solutions on glass slides, using a Chemat KW-4A
spin coater (PI-KEM, UK) at 2500 rpm for 15 s and then at
5000 rpm for 30 s. An average value was calculated from
five repeated measurements.
Source and preparation of stem cells
BMSCs were isolated from the femurs of Lewis rats and main-
tained by a modification of a previously described method.26
BMSCs were washed, centrifuged and plated into flasks con-
taining minimum essential medium (aMEM, Invitrogen
TM
,
Carlsbad, CA) supplemented with 1% penicillin–streptomycin
(PS) and 10% fetal bovine serum (FBS). Cells were harvested
from passages three to five. Osteogenic supplements (100 nM
dexamethasone, 10 mMb-glycerophosphate, and 0.05 mM
ascorbic acid) were added 4 days before seeding the cells
onto scaffolds. The study was approved by the Norwegian
Animal Research Authority and conducted according to the
European Convention for the Protection of Vertebrates Used
for Scientific Purposes (local approval number 20142029).
In vitro cell culture
Pristine poly(LLA-co-CL) scaffolds and scaffolds modified
with different concentrations of Tween 80 were prewet with
the culture medium and kept in an incubator at 378C and 5%
CO2 overnight. The BMSCs were then seeded on to the various
scaffolds placed at the bottom of wells in 96-well plates, at a
density of 2 3 106 cells/scaffold. An orbital shaker (Eppen-
dorfVR, Hamburg, Germany) was used for 5 min at 1000 rpm
to facilitate cell distribution within each scaffold.27 The cell/
scaffold grafts were incubated for 3 h to allow cell attachment
and then transferred to a TisXell Regeneration System (BXR)
(QuinXell International GmbH, Minden, Germany) and cul-
tured for 7 and 21 days. The scaffolds were classified accord-
ing to the percentage of Tween 80: poly(LLA-co-CL)/0.5%
Tween 80, poly(LLA-co-CL)/1% Tween 80, poly(LLA-co-CL)/
3% Tween 80, and poly(LLA-co-CL) (n58 per group). The
BXR was loaded with a total of 500 mL of osteogenic inductive
medium, filling the vessel and the reservoir. The entire bio-
reactor was placed in an incubator in a humidified atmos-
phere at 378C and 5% CO2. Gaseous exchange was enabled
through a special membrane incorporated into the spherical
vessel. The spherical vessel was programmed to rotate on two
perpendicular axes (X and Z), with both axial rotations set to
five rpm as previously described.28
Molecular weight measurement and Tween
80 composition
The number average molecular weight (Mn) and The Tween
80 composition of samples harvested after 7 and 21 days
were recorded by SEC and 1H NMR, respectively.
Cell proliferation assay
A MTT (3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium
bromide) assay measuring mitochondrial succinate dehydrogen-
ase activity was used as previously described.29 This colorimetric
assay is based on the ability of living cells to reduce yellow MTT
reagent (Sigma, St Louis, MO) to a purple formazan product.
Briefly, after 7 and 21 days, scaffolds were transferred into
96-well plates and washed with phosphate buffer solution (PBS).
Aliquots containing tetrazolium salt 3-(4,5-dimethylthiazolyle)-
2,5-diphenyltetrazolium bromide (1 mg/mL cell culture medium)
were added to each sample and incubated in the dark for 4 h at
378C, under a CO2 (5%) atmosphere. The MTTwas aspirated and
the formazan product was solubilized in 0.2 mL DMSO containing
6.25% (v/v) 0.1M NaOH. Absorbance was measured at 570 nm,
using a microplate reader (BMG LABTECH, GmbH, Germany).
Subcutaneous implantation
Based on the in vitro results, poly(LLA-co-CL)/3% Tween scaf-
folds were preselected for further investigation, with poly(LLA-
co-CL) scaffolds serving as controls. For in vivo evaluation, 14
healthy, skeletally mature male Lewis rats (2.5 months old,
weight: 300–350 g) were selected (7 rats for each time point).
The BMSCs were seeded onto the above preselected scaffold
types at a density of 23 106 cells/scaffold.13 One scaffold from
each experimental group was implanted into each animal, that
is, one poly(LLA-co-CL) and one poly(LLA-co-CL)/3% Tween
80 scaffold per animal giving a total of 28 implanted scaffolds.
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The animals were anesthetized with SevoFlo (sevoflurane,
Abbott Laboratories, UK) and oxygen mixture which was then
reduced to 2% during the surgical procedure. The animals
were placed in a ventral position, the backs shaved and disin-
fected. A small incision was made along the vertebral column.
Using blunt dissection, a pocket was created on both sides of
the incision and one scaffold/cell construct was inserted into
each pocket. The incisions were closed with Vicryl 4-0 sutures.
All animals were given a dose of buprenorphine (TemgesicV
R
0.3 mg/kg) intramuscularly as an analgesic and allowed to
recover. The status of the surgical wound, food intake, activity,
and signs of infection were monitored daily. The animals were
euthanized after 2 and 8 weeks and the implanted scaffolds
were harvested for further analysis.
Total RNA extraction and real-time polymerized
chain reaction (RT-PCR) analysis
RNA isolation and RT-PCR were undertaken as previously
described.30 Briefly, total RNA was isolated using an isolation
kit (E.Z.N.AVR) and purity and quantification were determined
by spectrophotometry (Nanodrop Spectrophotometer). For
PCR, cDNA was synthesized from the total RNA, using a
High-Capacity cDNA Archive kit (Applied Biosystems, Foster
City, CA) following the supplier’s instructions. RT-PCR was con-
ducted under standard enzyme and cycling conditions on a Ste-
pOne
TM
real-time PCR system, using TaqManVR gene expression
assays (Applied Biosystems
TM
). Vascular endothelial growth fac-
tor (VEGF), Platelet endothelial cell adhesion molecule (CD31),
bone related transcription factor (Runx2), alkaline phosphatase
(ALP) and osteocalcin (OC) were assessed. The data were ana-
lyzed using a comparative Ct method by StepOne. The relative
level of expression for each target gene was normalized by the
Ct value of TaqManV
R
Rodent housekeeping gene GAPDH, using
an identical procedure (2DCt formula, Perkin Elmer User Bulle-
tin #2). On analysis, undetected levels were scored as 0. Each
sample was analyzed in duplicate.
Quantification of ectopic bone
The harvested samples were fixed in 10% formalin for 2 days.
Radiographic analysis was undertaken using a l-CT scanner
(Skyscan 1172VR, Kontich, Belgium) with X-ray Source 50
kV/200 lA and a 0.5 mm aluminum filter (Al) for 10 lm reso-
lution. A global thresholding procedure was then performed
with a threshold level at 90/255. All samples were placed ver-
tically onto the sample holder. Tomographic acquired images
were transformed into sliced volumetric reconstruction using
NRecon ReconstructionVR (v. 1.6.10). Bone volume/tissue
volume (BV/TV) quantification was measured using the
CT-Analyzer program (v.1.15, Skyscan, Belgium) with upper
and lower grey value thresholds of 255 and100 respectively.
The imaging programs CTVoxVR (v.3.1) and CTVolVR (v.2.3)
were used to acquire 3D volume and surface rendering
images respectively.
Histology
Following scanning, all specimens were prepared for histolog-
ical evaluation. Harvested samples from each group were
decalcified in 10% EDTA at pH 7.4 for 14 days with a biweekly
change of solution and subsequently embedded in paraffin.
Sections near the central area of the implants were selected
for haematoxylin and eosin (H&E) and Masson’s Trichrome
(MT) staining.
Statistical analysis
Fourteen scaffolds from each group were available for the
statistical analysis in vitro and 14 rats were included in the
in vivo analysis. To provide accurate data of the hierarchical
structure of the outcome variables, a multilevel modelling
analysis was applied. For proliferation assays, four scaffold
replicates were repeated in triplicate for all experiments.
One-way analysis of variance (ANOVA) was used to test the
effect of the different Tween 80 concentrations on cell pro-
liferation. For PCR, reference values for different gene
expressions for each rat were calculated using mixed effects
models. Delta Ct (DCt) values were calculated as the gene
expression minus the calculated reference values. Next, a
general linear model, with robust variance estimators
adjusted for data clustering within rats, were applied. The
results expressed mean differences for the 2DCt values and
were presented as xFold values. For quantitative analysis of
bone formation (mean6 standard errors), Student’s t test
was used to compare pristine and modified scaffolds. Stata
version 13 (TX) was applied. p values less than 0.05 (5%)
were considered statistically significant.
RESULTS
Characterization of scaffolds
Blends of Tween 80 and copolymers were used to prepare
well-dispersed Tween 80 porous scaffold samples. Mn was
around 120,000 Da and the dispersity (-D) was around 1.5 for
all the materials. The copolymer contained 75 mol % LLA and
25 mol % CL as verified by 1H NMR.
SEM images of the surfaces of poly(LLA-co-CL) and poly
(LLA-co-CL)/Tween80 scaffolds are illustrated in Figure 2.
The images show the surface pattern and topography of
various scaffolds. (scale bar 100 nm).
The data generated by l-CT disclosed the surface area of
the various scaffolds (SA mm2), total porosity (P %), closed
porosity (%), and fractal dimension. All parameters are
described in Table I. Similar morphology was observed in
the pristine and copolymer/Tween scaffolds.
The modified scaffolds exhibited no change in porosity.
The mean pore size of the scaffolds was about 200 lm,
regardless of variation in chemical composition, with almost
100% interconnectivity (Figure 3). Adding low concentrations
of Tween 80 to the copolymer did not change the microstruc-
ture of the scaffolds.
The hydrophilicity of the scaffolds was evaluated in terms
of water contact angles. The contact angle of the pristine pol-
y(LLA-co-CL) was 86.6860.88. Incorporating low concentra-
tions of Tween 80 (0.5 and 1%) into the copolymer scaffolds
did not influence the surface contact angle (87.286 0.68 and
83.786 0.88, respectively). However, as shown in Figure 4(A),
there was a pronounced response to the blend of 3% Tween
80 and poly(LLA-co-CL) [55.386 5.38(p< 0.0001)]; the
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contact angles decreased significantly and water droplets
were rapidly absorbed [Figure 4(B)].
BMSCs were cultured on to the various scaffolds and
incubated in a BXR bioreactor for periods of 7 and 21 days.
At each time point Mn of poly(LLA-co-CL) was determined
by SEC (Figure 5). The scaffolds in all groups showed a
decrease in Mn throughout the entire incubation period.
The concentrations of Tween 80 in the various scaffolds
loaded with BMSCs and cultured in a dynamic environment
were measured by 1H MNR (Figure 6). The amount of
Tween 80 in the scaffolds modified by 0.5 and 1% Tween
80 remained unchanged, with no release of the surfactant.
However, almost 50% of the surfactant was released at day
7 from the scaffolds modified with 3% Tween 80.
Effect of hydrophilicity on BMSC proliferation
Cellular proliferation and metabolic activity in pristine and
modified copolymer scaffolds were monitored by MTT assay
for up to day 21 of culture. Figure 7 presents the metabolic
activity of BMSCs cultured onto the various scaffolds (pristine,
0.5%, 1% and 3% Tween 80), at day 7 and day 21. Regardless
of the chemical composition of the scaffold, BMSC prolifera-
tion increased during the culture period, with a statistically
significant increase for 3% Tween 80 at day 7 (p5 0.0004).
Moreover, compared with pristine scaffolds, cell proliferation
on the scaffolds modified with Tween 80 increased signifi-
cantly at day 21 (0.5% p5 0.025. 1% p5 0.0002, and 3%
p5 0.0003).
Effect of Tween 80 on bone formation
A rat subcutaneous model was used to study ectopic bone for-
mation in response to poly(LLA-co-CL)/Tween80 blend scaf-
folds. During the experiment, all the rats remained in good
health and there were no wound healing complications or any
signs of infection. Local expression of selected genes involved
in osteogenesis and angiogenesis were evaluated by real-time
PCR from the samples harvested 2 weeks post-implantation
(Figure 8). Compared with pristine scaffolds, mRNA expres-
sion of Runx2 was significantly upregulated in poly(LLA-co-
CL)/3% Tween 80 scaffolds (p5 0.004). Expression of CD31,
ALP, and OC was also increased, but not significantly
(p50.57, p50.367, p5 0.758, respectively). The mRNA
expression of VGEF was similar for both types of scaffold
(p50.95).
Formation of mineralized tissues was evaluated by l-CT
(Figure 9) and histology (Figure 10) after 8 weeks. The l-CT
analysis showed that the pristine scaffolds did not exhibit
much mineralized tissue formation: the percentage of bone vol-
ume/tissue volume was 0.22%6 0.24%. In contrast, the poly(-
LLA-co-CL)/Tween 80 scaffolds exhibited significantly
increased mineralized tissue formation of about 2.8%61.73%
(p5 0.013).
Histological analysis revealed similar tissue morphology
in and around the scaffold in both groups. The scaffolds were
composed of fibrous tissue with a fibrous tissue encapsula-
tion. In both groups, the scaffolds were infiltrated with foreign
body giant cells. Blood vessel formation was also observed.
Poly(LLA-co-CL)/3% Tween 80 scaffolds had large mineral-
ized islands (Figure 10) and newly formed tissues consisting
of viable osteocytes within lacunae embedded in osteoid-like
matrix. Osteoblast-like cells lined the surface of newly formed
bone, most likely producing the bone-like matrix.
DISCUSSION
Tween 80 was selected as the hydrophilic additive because it
does not readily leach out into water or cell culture medium. In
agreement with previous findings it was found that Tween 80
blends readily in to polymer: hydrophobic interaction between
the hydrophobic tail of Tween 80 and the polymer main chain
provides homogenous distribution and stability of Tween 80
within the copolymer.23,31 Moreover, a low concentration of
Tween 80 increases the hydrophilicity of poly(LLA-co-CL)
FIGURE 2. SEM images of poly(LLA-co-CL) and poly(LLA-co-CL)/Tween 80 scaffolds. The images demonstrate surface pattern and topography of
various scaffolds (scale bar 100 nm).










Poly(LLA-co-CL)/0.5% Tween 80 25.376 0.67 84.9960.36 0.001760.00096 2.636 0.075
Poly(LLA-co-CL)/1% Tween 80 25.436 1.31 85.0360.4 0.001560.00036 2.626 0.067
Poly(LLA-co-CL)/3% Tween 80 25.906 0.3 85.9360.76 0.001560.00042 2.566 0.058
Poly(LLA-co-CL) 26.736 0.67 88.5760.45 0.001660.0036 2.596 0.047
ORIGINAL ARTICLE
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH A | AUG 2016 VOL 104A, ISSUE 8 2053
scaffolds without any changes in surface topography and ther-
mal properties.23 Poly(LLA-co-CL) and poly(LLA-co-CL)/Tween
80 scaffolding materials were synthesized by ring opening
polymerization. These copolymers were further processed into
3D porous scaffolds with interconnected pores which allow
ingrowth of tissue following in vivo implantation.
Microstructure analysis revealed an adequate scaffold
porosity range for bone tissue engineering applications and
FIGURE 3. Pore size distributions and pore size range determined by l-CT. No differences in pore size distribution were found.
FIGURE 4. Water contact angle of poly(LLA-co-CL) and Tween 80 modified scaffolds (A) contact angle values and (B) the corresponding images
of contact angles. Compared with pristine poly(LLA-co-CL), poly(LLA-co-CL)/3% Tween 80 showed a significant reduction in the contact angle
(p< 0.001) (*p 0.05, **p 0.01, ***p 0.001).
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a pore size within acceptable range for supporting bone
ingrowth.32 3D analysis of the scaffolds showed similar
internal structures for poly(LLA-co-CL) and poly(LLA-co-CL)/
Tween 80 formulations with highly interconnected pores. Fur-
thermore, no differences in fractal dimension were detected
among the scaffolds. Fractal dimension expresses the rough-
ness or complexity of the microstructure, which is the repeti-
tive pattern of gray scale configurations, as previously
described33 and is related to the microstructure properties of
polymer scaffolds or trabecular bone. Tween 80 concentra-
tions might potentially affect the mechanical properties of the
copolymers.23,31 The plasticizing effect of Tween 80 probably
depends on the concentration in the polymer matrix; the
higher the Tween 80 concentration, the softer the polymer.
However, l-CT characterization was conducted on dry scaf-
folds. Under physiological conditions a change in pore size
depending on the surface properties, for example, wettability,
would be likely due to swelling and uptake of water.
A reduction in molecular weight is an essential change to
porous scaffolds during degradation, which might lead to
changes in the scaffold properties.34 In general, the degradation
of poly(LLA-co-CL) via hydrolysis is caused by random cleavage
of main chain ester bonds, which leads to a reduction in the
polymer molecular weight.35–37 In addition, enzymatic degra-
dation can occur in scaffolds seeded with cells.38 The hydrolytic
degradation rate of aliphatic polyesters is affected by water
absorption and material crystallinity.9 Usually a significant
change of molecular weight of polymer scaffolds is observed at
a late stage of degradation when the degraded compounds,
which are usually oligomers, become water soluble and are
flushed away. The fastest degradation occurred with poly
(LLA-co-CL)/3% Tween 80, indicating accelerated reduction in
the molecular weight of poly(LLA-co-CL) in the hydrophilicity
adjustment process. In addition, the rapid degradation rate
observed in vitro is most likely due to cellular and enzymatic
activities on poly(LLA-co-CL) and poly(LLA-co-CL)/Tween 80
scaffold surfaces. A third factor in this acceleration might be
FIGURE 5. In vitro mean changes in the average number molecular
weight (Mn) of pristine poly(LLA-co- CL) porous scaffolds following
modification with 0.5, 1, and 3% Tween 80. The scaffolds were seeded
with BMSCs and cultured in a BXR bioreactor for up to 21 days.
FIGURE 6. Tween 80 concentrations in scaffolds seeded with BMSCs
and cultured for 7 and 21 days. The percentages of Tween 80 were
evaluated by 1H NMR spectra.
FIGURE 7. Quantitative analysis of metabolic activity of BMSCs
seeded on pristine poly(LLA-co-CL) and modified Tween 80 scaffolds
under dynamic cell culture. The columns present “absorbency at 570
nm”. There is a significant increase in cell proliferation in response to
3% Tween 80 at days 7 and 21 (p5 0.0004 and p5 0.0003, respec-
tively). At day 21 significantly increased cell proliferation was
observed on Tween 80 modified scaffolds (0.5% Tween 80 (p50.025)
and 1% Tween 80 (p50.0002) (*p 0.05, **p0.01, ***p 0.001).
FIGURE 8. mRNA expression profiles of VEGF, CD31, Runx2, ALP, and
OC by qRT-PCR, presented as x-fold changes after 2 weeks of subcuta-
neous implantation of poly(LLA-co-CL) and poly(LLA-co-CL)/3% Tween
80 in Lewis rats. A significant upregulation of Runx2 (p50.004) was
detected in 3% Tween 80 scaffolds. (*p 0.05, **p 0.01).
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FIGURE 9. l-CT of copolymer scaffolds loaded with BMSCs: 8 weeks post-implantation in a subcutaneous Lewis rat model. A: The histogram
illustrates the statistical difference in bone/tissue formation between pristine poly(LLA-co-CL) and poly(LLA-co-CL)/3% Tween 80 modified
scaffolds (p5 0.013). B: l-CT images of subcutaneously implanted polymer scaffold loaded with BMSCs after 8 weeks showing de novo bone
formation. 3D reconstructed images; A–F using CTVox software, while D and H using CTVol software. A–D pristine poly(LLA-co-CL) scaffolds.
E–H poly(LLA-co-CL)/3% Tween 80 (*p 0.05).
FIGURE 10. Haematoxylin and eosin (H&E) (A–D) and Masson’s trichrome (MT) (E–H) staining of the polymer scaffold 8 weeks post-implantation
in Lewis rats. Arrows indicate mineralized tissue (scale bar 100 lm).
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high perfusion of medium into the scaffold matrix, in a dynamic
flowing environment to remove the degradation compounds
rapidly by an increased diffusion rate. Taken together, the
weight loss of poly(LLA-co-CL)/Tween 80 scaffolds, in combi-
nation with dynamic cell culture, implies a release of Tween
80 from the scaffolds. These results are in accordance with pre-
vious reports indicating that release of Tween 80 from copoly-
mer films31 and loss of Tween 80 are most likely attributable
to rapid degradation of polymer material from the surface,
leading to further exposure and release of Tween 80.
The potential for water uptake is intrinsically related to the
affinity of the copolymer for water and it can be affected by sur-
face tension, which is partially responsible for and directly
related to the degree of cell adhesion to the scaffold surface.39 In
addition, the surface chemistry of biomaterials may influence
which serum proteins adhere to their surface, directly impacting
biological responses, such as cell adhesion.40 When a material is
exposed to a body fluid or culture medium, one of the first cell–
material interactions to occur at the solid/liquid interface is pro-
tein adsorption. Cellular adhesion to most TE scaffolds involves
a two-step process: ECM proteins present in serum and/or tis-
sues adsorb onto the scaffold surface and the cells then adhere
to these proteins.41 Therefore, both the structure and composi-
tion of this protein layer are crucial determinants of cell adhe-
sion and further cell proliferation.42 Over time, BMSCs grew in
all scaffolds, but the poly(LLA-co-CL)/3% Tween 80 scaffolds
exhibited enhanced cell proliferation. Therefore, increased
hydrophilicity of the scaffolds can allow uniform cell seeding at
the initial stage, through the homogeneous absorption of culture
medium containing cells, providing an optimal microenviron-
ment for physiological cellular activity.43 Better cell proliferation
is probably attributable to preferential adsorption of some
serum proteins such as fibronectin and vitronectin from the cul-
ture medium onto the moderately hydrophilic surfaces. However,
cell–material interactions are determined not only by the hydro-
philic character of material surfaces or surface charge: the cul-
ture condition and surface roughness may also contribute to the
observed behavior of the BMSCs.28 In the present study, SEM
images revealed that surface topography of poly(LLA-co-CL)/3%
Tween80 scaffolds was different from the topography of the con-
trol scaffolds. Both in vitro and in vivo, the roughness of the
material surface influences cellular morphology, proliferation,
and phenotype expression. For instance, rat osteoblasts exhibit
higher proliferation and expression of ALP and OC on rough
surfaces than on smooth.44
An advantage of the subcutaneous implantation model is
that under physiological conditions, natural bone-forming
cells do not occur in the intradermal environment. Thus in
theory, the newly formed bone is predominantly of exogenous
origin. Osteogenic differentiation of BMSC is a key process for
bone regeneration. It is a complex process in which serial
steps are tightly regulated by a number of factors in a time-
dependent fashion.45 The upregulation of osteogenic genes in
poly(LLA-co-CL)/3%Tween 80 indicates that improved
hydrophilicity of copolymer scaffolds favors more rapid osteo-
genic induction of cells.23 It is suggested that the increased
hydrophilicity of the surface might allow formation of a fila-
mentous F-actin cytoskeletal network in the cells initiating
osteogenic differentiation of MSCs.46 Runx 2 is thought to play
a central role in regulating the stem cells into an osteoblastic
biotype, by directly stimulating the expression of downstream
osteogenic genes such as alkaline phosphatase, bone sialopro-
tein, and osteocalcin.47 Previously published reports have
demonstrated that improved wettability of materials can pro-
mote osteogenic differentiation of BMSCs in vitro.48 Moreover,
studies on titanium dental implants have reported that chemi-
cal modulation to increase hydrophilicity of the surface may
lead to more successful osseointegration through bone mor-
phogenetic protein signaling.49 The BMSCs gene expression
profiles indicate that tuning the hydrophilicity of poly(LLA-co-
CL) scaffolds might increase the osteoconductive potential
and allowing rapid in vivo fluid infiltration and consequently
stable blood clot formation, which is known to initiate the
healing cascade, eventually leading to bone ingrowth.50 The
physical and chemical properties of the carrier are critical fac-
tors for bone formation.32,51 The mineralized tissues observed
on scaffolds modified with 3% Tween 80 contributed to
altered surface properties. Studies on titanium dental
implants show that chemically modified surfaces retain the
topography of the original surface, but increasing hydrophilic-
ity induces greater bone to implant contact, osteoblast differ-
entiation, growth factor production, and osteogenic gene
expression.52 Similarly, it has been demonstrated that surface
treatment of PCL scaffolds with tricalcium phosphate
increases the wettability and initial bone ingrowth.53
Vascularization is another essential factor for BTE con-
structs as it determines the extent of blood supply, oxygen,
nutrients, and exchange of waste products within the host tis-
sue infiltrating the scaffold. Angiogenesis/neo-vascularization
associated with implanted biomaterials is dependent on a num-
ber of factors, including the bioactive nature of the scaffold, the
porosity, pore interconnectivity, and the metabolic activity of
the infiltrating host tissue.54 The scaffolds used in this study
comprised a highly porous structure (porosity about 85%),
with well-defined interconnectivity (100%). It was observed
that the internal porous structure of both scaffolds was pre-
served during 8 weeks of implantation; this in turn allowed
infiltration of host cells and formation of mineralized tissues in
the scaffolds. Importantly, after 8 weeks of implantation, more
tissue formation was observed in poly(LLA-co-CL)/3% Tween
80 scaffolds than in poly(LLA-co-CL) scaffolds indicating more
rapid integration of poly(LLA-co-CL)/3% Tween 80 scaffolds,
due to favorable surface properties. The tissue response to the
implanted scaffold depends on the scaffold’s surface; hence this
is the most vital site of acute immune host response following
implantation. The hydrophilic surfaces may reduce the adhe-
sion of monocytes and increase the number of adherent apo-
ptotic macrophages, thereby reducing the risk of implant
failure.55,56 In BTE, the preferred scaffolding material should
exert a positive modulating influence on the immune system
and subsequently enhance bone repair and regeneration.57
CONCLUSION
Based on the results of these in vitro and in vivo studies it
is concluded that blending of 3% (w/w) of Tween 80 with
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poly(LLA-co-CL) scaffolding material significantly improves
the hydrophilicity and osteogenic potential of the scaffolds.
Tuning surface wettability has a positive influence on the
surface characteristics of the scaffolds without adversely
affecting the microstructural properties. The 3% Tween
80 porous degradable scaffolds absorb water quickly, signifi-
cantly increase BMSC proliferation in vitro up to 21 days,
promote osteogenic differentiation of BMSCs, and signifi-
cantly increase de novo bone formation.
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